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Introduction	  	   Cerebrovascular	  disease	  is	  the	  fourth	  leading	  cause	  of	  death	  in	  the	  United	  States	  and	  the	  most	  common	  cause	  of	  adult	  disability	  (National	  Institute	  of	  Neurological	  Disorders	  and	  Stroke,	  2013).	  	  The	  annual	  costs	  of	  ischemic	  cerebrovascular	  disease	  in	  the	  United	  States	  exceed	  $73.7	  billion	  (American	  Stroke	  Association,	  2010).	  	  By	  2020,	  stroke	  will	  become	  the	  leading	  cause	  of	  death	  and	  disability	  worldwide	  (World	  Health	  Organization,	  2010).	  	  Unlike	  other	  organs	  of	  the	  body,	  the	  brain	  has	  limited	  energy	  reserves	  and	  any	  disruption	  in	  blood	  supply	  is	  critical	  and	  results	  in	  a	  cascade	  of	  events	  ultimately	  leading	  to	  loss	  of	  brain	  tissue	  and	  function.	  	  Persons	  sustaining	  a	  stroke	  may	  experience	  loss	  of	  movement	  and/or	  ability	  to	  perceive	  sensation,	  inability	  to	  speak	  or	  understand,	  and/or	  loss	  of	  vision.	  	  Death	  occurs	  in	  approximately	  30%	  of	  stroke	  victims	  (ASA,	  2010).	  	  It	  has	  been	  estimated	  that	  up	  to	  80%	  of	  strokes	  are	  preventable	  by	  controlling	  risk	  factors,	  such	  as	  hypertension,	  tobacco	  abuse,	  dyslipidemia,	  and	  glucose	  intolerance	  (NINDS,	  2013).	  	  Risk	  factors,	  refractory	  to	  stroke	  risk	  reduction	  include	  age,	  genetics,	  race	  and	  gender.	   	   	   	   	   	   	   	   	   	   	   	  
	   The	  benefits	  of	  primary	  care	  based	  interventions	  of	  lifestyle	  modification,	  education,	  pharmacological	  treatment,	  counseling,	  and	  effective	  community	  education	  programs;	  are	  vital	  to	  increase	  public	  awareness	  of	  stroke	  and	  decrease	  incidence	  (American	  Heart	  Association/American	  Stroke	  Association,	  2011;	  Yoon,	  &	  Byles	  2002).	  	  The	  vast	  majority	  of	  these	  events	  can	  potentially	  be	  prevented	  if	  translation	  of	  evidence	  to	  healthcare	  professionals	  and	  the	  public	  at	  large	  denoting	  specific	  risk	  factors	  and	  interventions	  are	  successful.	  	  However,	  the	  incidence	  of	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stroke	  remains	  high	  despite	  evidence-­‐based	  advances	  in	  prevention	  and	  treatment.	  	  Men	  have	  a	  higher	  incidence	  of	  stroke	  in	  almost	  every	  age-­‐specific	  grouping	  when	  compared	  to	  women.	  	  The	  exceptions	  are	  ages	  35	  to	  44	  and	  >85	  years	  of	  age.	  	  Yet,	  despite	  the	  overall	  higher	  incidence	  of	  strokes	  in	  the	  male	  population,	  women	  have	  a	  higher	  rate	  of	  death	  from	  stroke	  (ASA/AHA,	  2011).	  	  Important	  risk	  factors	  for	  women	  under	  the	  age	  of	  55	  include:	  migraines,	  birth	  control	  pills,	  hormone	  replacement	  therapy,	  autoimmune	  diseases	  (e.g.,	  diabetes	  and	  lupus),	  and	  clotting	  disorders	  (AHA/ASA,	  2011).	  The	  inability	  to	  disseminate	  critical	  information	  about	  stroke	  awareness	  in	  a	  form	  that	  is	  accessible,	  understood,	  internalized	  and	  results	  in	  improved	  health	  care	  habits	  limits	  the	  ability	  of	  evidence-­‐based	  practice	  to	  affect	  stroke	  occurrence	  and	  treatment.	   	   	   	  	   Analysis	  of	  the	  American	  Heart	  Association/American	  Stroke	  Association	  2011	  Primary	  Stroke	  Prevention	  Guidelines	  and	  the	  American	  Heart	  Association/American	  Stroke	  Association	  2014	  Guidelines	  for	  the	  Prevention	  of	  Stroke	  in	  Women	  have	  shown	  that	  a	  knowledge	  gap	  exists	  about	  what	  is	  known	  about	  stroke	  and	  the	  public’s	  awareness.	  	  Women	  appear	  to	  be	  more	  knowledgeable	  regarding	  stroke	  symptoms	  and	  interventions,	  but	  have	  been	  found	  to	  have	  a	  longer	  wait	  time	  to	  seek	  emergent	  care	  than	  their	  male	  counterparts	  (AHA/ASA,	  2014).	  	  The	  AHA/ASA	  (2014)	  has	  also	  defined	  an	  even	  lower	  knowledge	  deficit	  in	  the	  minority	  women	  population.	   	   	  	   Despite	  advances	  in	  knowledge	  and	  management	  of	  modifiable	  risk	  factors	  and	  acute	  therapeutic	  intervention	  stroke,	  awareness	  remains	  limited,	  not	  only	  in	  terms	  of	  stroke	  symptoms	  and	  stroke-­‐risk	  factors,	  but	  also	  in	  terms	  of	  appropriate	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response	  when	  symptoms	  occur	  (Miller	  &	  Spilker,	  2003;	  Das,	  Mondal,	  Dutta,	  Mukherjee	  &	  Mukherjee,	  2007;	  Reeves,	  Hogan	  &	  Rafferty,	  2002;	  Pancioli,	  Braderick	  &	  Kothari,	  1998).	  	  The	  purpose	  of	  this	  capstone	  project	  is	  to	  explore	  strategies	  for	  stroke	  prevention.	  	  A	  review	  of	  the	  literature	  on	  the	  effect	  of	  educational	  interventions	  on	  stroke	  awareness	  is	  the	  focus	  of	  the	  first	  manuscript.	  	  The	  second	  manuscript	  will	  analyze	  the	  2014	  Guidelines	  for	  the	  Prevention	  of	  Stroke	  in	  Women:	  A	  Statement	  for	  Healthcare	  Professionals	  from	  the	  American	  Heart	  Association/American	  Stroke	  Association.	  	  One	  of	  the	  many	  independent	  and	  modifiable	  risk	  factors	  for	  stroke	  is	  diabetes	  (Hewitt,	  Castilla	  Guerra,	  Fernández-­‐Moreno,	  &	  Sierra,	  2012).	  	  Diabetes	  affects	  over	  25	  million	  people	  and	  is	  the	  7th	  leading	  cause	  of	  death	  in	  the	  United	  States	  (Centers	  for	  Disease	  Control,	  2011).	  A	  diabetic	  individual’s	  risk	  for	  stroke	  and	  death	  from	  stroke	  are	  2	  to	  4	  times	  higher	  than	  those	  without	  diabetes	  (AHA/ASA,	  2011;	  CDC,	  2012;	  Hewitt	  et	  al.,	  2012).	  	  Maintaining	  strict	  glycemic	  control	  is	  not	  the	  only	  source	  of	  intervention	  for	  reducing	  stroke	  risk.	  	  Based	  on	  data	  from	  multiple	  randomized	  clinical	  trials	  the	  AHA/ASA	  guidelines	  recommend	  diabetic	  patients	  receive	  an	  HMG-­‐CoA	  reductase	  inhibitor	  (statin)	  even	  in	  the	  presence	  of	  normolipidemia	  and	  cholesterol,	  to	  decrease	  primary	  stroke	  incidence	  (AHA/ASA,	  2011;	  Heart	  Protection	  Study,	  2002;	  Hewitt	  et	  al.,	  2012;	  Page,	  Sanfilippo,	  Geelhoed,	  Briifa	  &	  Hobbs,	  2012).	  	  The	  third	  manuscript	  in	  this	  capstone	  project	  examines	  providers’	  adherence	  to	  the	  AHA/ASA	  guidelines.	  	  The	  Advanced	  Practice	  Nurse	  is	  presented	  with	  important	  instrumental	  challenges	  to	  effect	  changes	  in	  the	  way	  individuals	  and	  communities	  perceive	  strokes.	  Thorough	  knowledge	  of	  effective	  educational	  approaches	  for	  behavioral	  
	   4	  
modification	  is	  vital	  if	  the	  goal	  of	  reducing	  stroke	  occurrence	  utilizing	  evidence-­‐based	  practice	  is	  to	  be	  realized.	  	  	  	   The	  intent	  of	  this	  DNP	  practice	  inquiry	  project	  is	  to	  emphasize	  the	  importance	  of	  stroke	  awareness,	  examine	  the	  successes	  and	  failures	  of	  strategies	  utilized	  for	  improving	  public	  knowledge,	  explore	  the	  possibilities	  for	  developing	  more	  efficient	  educational	  modalities	  to	  reduce	  stroke	  prevalence,	  to	  examine	  the	  AHA/ASA	  Stroke	  prevention	  guidelines	  related	  to	  women	  and	  research	  a	  specific	  primary	  stroke	  intervention	  for	  one	  of	  the	  many	  modifiable	  risk	  factors	  (diabetes).	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Abstract	  Strokes	  are	  the	  fourth	  leading	  cause	  of	  death	  in	  the	  United	  States	  and	  one	  of	  the	  most	  common	  causes	  of	  adult	  disability	  (National	  Institute	  of	  Neurological	  Disorders	  and	  Stroke,	  2013).	  	  It	  has	  been	  estimated	  that	  up	  to	  80%	  of	  strokes	  are	  preventable	  by	  controlling	  risk	  factors	  (NINDS,	  2013).	  	  Despite	  recent	  advances	  in	  prevention	  and	  treatment	  for	  stroke,	  public	  awareness	  of	  stroke	  is	  markedly	  limited	  (Goldstein	  et	  al.,	  2011).	  	  Developing	  and	  implementing	  an	  effective	  educational	  tool	  targeted	  at	  informing	  the	  public	  of	  stroke	  intervention	  is	  a	  healthcare	  priority.	  	  Nine	  studies	  were	  reviewed	  regarding	  the	  lack	  of	  awareness	  of	  cerebrovascular	  disease,	  its	  implications	  and	  ways	  to	  reduce	  the	  prevalence	  of	  cerebrovascular	  accidents.	  This	  review	  showed	  a	  large	  gap	  in	  public	  awareness	  of	  stroke	  in	  the	  context	  of	  risk	  factors,	  signs	  and	  symptoms,	  and	  potential	  for	  prevention	  and	  treatment.	  	  The	  challenge	  will	  be	  to	  develop	  new	  and	  novel	  evidence-­‐based	  educational	  approaches	  for	  modifying	  and	  reducing	  the	  incidence	  of	  stroke	  in	  culturally	  and	  racially	  diverse	  groups.	  	  Key	  Words:	  	  stroke,	  prevention,	  education,	  warning	  signs,	  risk	  factors,	  awareness	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Stroke	  Awareness:	  Implications	  and	  Strategies	  for	  Improvement	  
Introduction	  Cerebrovascular	  infarct	  or	  hemorrhage	  (stroke)	  is	  the	  fourth	  leading	  cause	  of	  death	  and	  one	  of	  the	  most	  common	  causes	  of	  adult	  disability	  in	  the	  United	  States	  and	  currently	  the	  second	  leading	  cause	  of	  death	  worldwide	  (Center	  for	  Disease	  Control,	  2013;	  NINDS,	  2013;	  World	  Health	  Organization,	  2013).	  	  By	  2020,	  stroke	  will	  become	  the	  leading	  cause	  of	  death	  and	  disability	  worldwide	  (WHO,	  2004).	  	  	  Stroke	  results	  from	  a	  disruption	  of	  the	  blood	  supply	  to	  the	  brain.	  	  Loss	  of	  blood	  supply	  secondary	  to	  a	  circulatory	  vessel	  occlusion	  results	  in	  a	  cascade	  of	  events,	  ultimately	  leading	  to	  loss	  of	  brain	  tissue	  and	  function.	  Persons	  sustaining	  a	  stroke	  may	  experience	  loss	  of	  movement	  and/or	  ability	  to	  perceive	  sensation,	  inability	  to	  speak	  or	  understand,	  and/or	  loss	  of	  vision.	  	  	  On	  average	  795,000	  new	  strokes	  or	  recurrent	  strokes	  transpire	  annually	  within	  the	  United	  States,	  with	  approximately	  30%	  of	  these	  resulting	  in	  death	  (American	  Stroke	  Association,	  2012;	  ASA,	  2010;	  NINDS,	  2013).	  	  	   It	  has	  been	  estimated	  that	  up	  to	  80%	  of	  strokes	  are	  preventable	  by	  controlling	  risk	  factors	  (NINDS,	  2013).	  	  The	  risks	  of	  sustaining	  a	  stroke	  may	  be	  either	  modifiable	  or	  unalterable.	  	  Some	  of	  the	  major	  risk	  factors	  that	  are	  subject	  to	  reduction	  include	  hypertension,	  tobacco	  abuse,	  dyslipidemia,	  and	  glucose	  intolerance.	  	  Risk	  factors	  refractory	  to	  stroke	  risk	  reduction	  include	  age,	  genetics,	  race,	  and	  gender	  (ASA,	  2012).	  	  	  	   Despite	  advances	  in	  knowledge	  and	  management	  of	  modifiable	  risk	  factors	  and	  acute	  intervention	  in	  the	  treatment	  of	  stroke,	  there	  is	  limited	  improvement	  in	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the	  public’s	  knowledge	  of	  the	  symptoms	  and	  signs	  of	  stroke,	  stroke-­‐risk	  reduction	  behavior,	  and	  importance	  of	  early	  recognition	  and	  treatment	  (Miller	  &	  Spilker,	  2003;	  Das,	  Mondal,	  Dutta,	  Mukherjee	  &	  Mukherjee,	  2007).	  	  Effective	  educational	  interventions	  to	  increase	  public	  awareness	  and	  compliance	  need	  to	  be	  identified.	  Investigations	  to	  delineate	  the	  most	  effective	  method(s)	  have	  been	  limited	  or	  marginally	  successful	  (Goldstein	  et	  al.,	  2011;	  Davis,	  Martinelli,	  Braxton,	  Kutrovac,	  &	  Crocco,	  2009;	  Miller	  &	  Spilker,	  2003).	  	  More	  research	  into	  developing	  instructional	  materials	  that	  result	  in	  enhanced	  awareness	  and	  retention	  is	  mandatory	  if	  the	  occurrence	  of	  strokes	  is	  to	  be	  reduced.	  	  Boden-­‐Albala	  et	  al.	  (2010)	  have	  shown	  that	  not	  only	  were	  less	  than	  half	  of	  a	  population	  of	  lay	  individuals	  aware	  of	  risk	  factors	  and	  symptoms,	  but	  also	  that	  a	  gap	  existed	  between	  knowledge	  and	  application.	  	   The	  Advanced	  Practice	  Nurse	  is	  presented	  with	  important	  instrumental	  challenges	  to	  effect	  changes	  in	  the	  way	  individuals	  and	  communities	  perceive	  strokes.	  	  Thorough	  knowledge	  of	  effective	  educational	  approaches	  for	  behavioral	  modification	  is	  vital	  if	  the	  goal	  of	  reducing	  stroke	  occurrence	  utilizing	  evidence-­‐based	  practice	  is	  to	  be	  realized.	  	  The	  intent	  of	  this	  integrative	  review	  is	  to	  emphasize	  the	  importance	  of	  stroke	  awareness,	  examine	  the	  successes	  and	  failures	  of	  strategies	  utilized	  for	  improving	  public	  knowledge,	  and	  explore	  the	  possibilities	  for	  developing	  more	  efficient	  educational	  modalities	  to	  reduce	  stroke	  prevalence.	  	   	  
Critique	  of	  Relevant	  Research	  Literature	  	   Using	  the	  key	  words	  of	  “Stroke	  Awareness”,	  “	  Stroke	  Education”,	  Stroke	  Intervention”,	  and	  “Stroke	  Risk	  Factors”	  an	  extensive	  review	  of	  the	  literature	  was	  conducted	  using	  CINAHL,	  PUBMED,	  Web	  of	  Science,	  MEDLINE,	  and	  Science	  Direct.	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Inclusion	  criteria	  were:	  (a)	  primary	  study	  in	  nursing	  or	  medicine	  published	  in	  English;	  (b)	  investigation	  of	  the	  general	  knowledge	  regarding	  risk	  factors,	  causes,	  and	  potential	  intervention	  for	  stroke;	  and	  (c)	  use	  of	  instructional	  strategies	  for	  enhancing	  public	  awareness	  of	  stroke	  for	  efficacy	  and	  knowledge	  retention.	  	  	  
Study	  Design	  and	  Methodology	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   A	  variety	  of	  study	  designs	  were	  used	  to	  assess	  general	  stroke	  awareness.	  Two	  randomized	  control	  studies,	  three	  experimental	  prospective	  pretest/posttest,	  two	  quantitative	  cross-­‐sectional	  surveys,	  one	  quantitative	  prospective	  survey,	  and	  one	  qualitative	  cross-­‐sectional	  studies	  met	  the	  criteria	  for	  this	  review.	  	  All	  studies	  had	  purposive	  or	  convenience	  sampling.	  	  Sample	  sizes	  ranged	  from	  60	  to	  4000	  subjects	  varying	  in	  age	  (13	  to	  75),	  ethnicity,	  level	  of	  education,	  socio-­‐economic	  status,	  and	  included	  both	  genders	  (Miller	  &	  Spilker,	  2003;	  Das	  et	  al.,	  2007).	  	  Most	  studies	  (8)	  included	  only	  asymptomatic	  individuals,	  while	  three	  studies	  included	  both	  individuals	  who	  had	  and	  had	  not	  sustained	  a	  stroke.	  	  Five	  studies	  were	  community	  based	  and	  four	  were	  hospital	  based.	  Both	  randomized	  studies	  were	  community	  based	  and	  included	  only	  asymptomatic	  individuals.	  	  All	  nine	  studies	  included	  a	  vulnerable	  population,	  e.g.,	  children;	  elderly;	  or	  students	  in	  their	  samples,	  but	  only	  three	  studies	  (Boden-­‐Albala	  et	  al.,	  2009;	  Miller	  &	  Spilker,	  2003;	  Miller,	  et	  al.,	  2007)	  mentioned	  utilizing	  informed	  consent,	  or	  providing	  opportunity	  to	  decline	  participation.	  	  Five	  of	  nine	  studies	  used	  computer-­‐generated	  random	  assignment	  to	  appoint	  participants	  to	  either	  the	  control	  group	  or	  intervention	  groups	  (Boden-­‐Albala	  et	  al.,	  2010;	  Miller	  &	  Spilker,	  2003;	  Davis	  et	  al.,	  2009;	  Hickey,	  O’Hanlon,	  McGee,	  et	  al.,	  2009;	  Schneider,	  Pancioli,	  Khoury,	  et	  al.,	  2003).	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Key	  Findings	  	   	   	  	  	  	  	  	  	   	   	   	   	   	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   	  	  	  	  	  
	   Variations	  of	  Educational	  Interventions:	  Are	  They	  Effective?	   	  	   Only	  six	  of	  the	  studies	  investigated	  baseline	  knowledge	  of	  stroke	  and	  the	  effectiveness	  of	  an	  educational	  tool.	  	  Differing	  study	  designs	  were	  used	  to	  assess	  general	  stroke	  awareness.	  	  All	  six	  studies	  were	  quantitative	  and	  five	  out	  of	  the	  six	  used	  pretests	  and	  posttests,	  (Boden-­‐Albala	  et	  al.,	  2010;	  Davis	  et	  al.,	  2009;	  Miller	  et	  al.,	  2007;	  Miller	  &	  Spilker,	  2003;	  Hwang,	  et	  al.,	  2010)	  while	  one	  used	  a	  cross-­‐sectional	  survey	  method	  (Silver,	  et	  al.,	  2003).	  	  The	  independent	  variables	  in	  these	  quantitative	  studies	  were	  related	  to	  a	  specific	  educational	  tool	  used	  to	  educate,	  reinforce,	  and	  retain	  stroke	  knowledge.	  	  The	  dependent	  variables	  were	  comprehension,	  application,	  and	  retention	  of	  stroke	  knowledge.	  	   Multiple	  data	  collection	  methods	  were	  used,	  including	  surveys	  (multiple	  choice,	  hypothetical	  scenarios,	  and	  open-­‐ended	  questions),	  in-­‐person	  and	  telephone	  interviews,	  self-­‐assessments,	  and	  questionnaires.	  	  Also,	  a	  variety	  of	  educational	  tools	  and	  instruments	  were	  used	  in	  these	  data	  collections,	  thus	  making	  comparison	  between	  studies	  difficult.	  	  Even	  though	  most	  educational	  tools	  showed	  significant	  improvement	  from	  baseline	  stroke	  knowledge,	  no	  single	  educational	  tool	  appeared	  to	  be	  ideal	  for	  the	  diversity	  of	  all	  populations.	  	   	   	  	   Davis	  et	  al.,	  (2009)	  found	  that	  by	  using	  posters	  there	  was	  improvement	  from	  baseline	  but	  posters,	  did	  not	  significantly	  improve	  the	  knowledge	  and	  retention	  of	  the	  signs	  and	  symptoms	  of	  stroke.	  	  Boden-­‐Albala	  et	  al.,	  (2010)	  recorded	  time	  from	  symptom	  onset	  to	  ED	  arrival:	  the	  mean	  was	  46	  hours	  and	  the	  median	  was	  12.9	  hours.	  	  The	  time	  to	  ED	  arrival	  differed	  significantly	  among	  different	  ethnic	  groups	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and	  educational	  levels.	  	  This	  translated	  significantly	  to	  the	  overall	  mean	  baseline	  stroke	  knowledge	  survey	  score	  between	  each	  ethnic	  group	  and	  educational	  level	  (p<0.01).	  	  Boden	  et	  al.,	  (2010),	  also	  recorded	  baseline	  stroke	  knowledge	  through	  a	  structured,	  in-­‐person	  interview	  that	  included:	  demographics,	  psychosocial,	  socioeconomic	  factors,	  medical	  history,	  vascular	  risk	  factors,	  family	  history	  of	  stroke	  and	  cardiac	  disease,	  cognitive	  battery,	  and	  functional	  assessment.	  	  These	  standardized	  questions	  were	  adapted	  from	  the	  Behavioral	  Risk	  Factor	  Surveillance	  System.	  	  This	  information	  was	  collected	  before	  engaging	  the	  Stroke	  Warning	  Information	  and	  Faster	  Treatment	  Study	  (SWIFT).	  	  SWIFT	  is	  a	  culturally	  tailored	  interactive	  stroke	  preparedness	  educational	  intervention	  that	  was	  used	  to	  measure	  stroke	  knowledge.	  	  The	  study	  compared	  the	  SWIFT	  interventional	  groups	  against	  basic	  stroke	  education.	  	  These	  findings	  have	  yet	  to	  be	  disseminated	  and	  only	  baseline	  knowledge	  of	  the	  study’s	  participants	  is	  being	  reviewed.	  	  Using	  the	  FAST	  stroke	  interventional	  program,	  Miller	  et	  al.,	  (2007)	  found	  significantly	  improved	  knowledge	  of	  stroke	  warning	  signs	  and	  risk	  factors	  among	  middle	  school	  students	  (p<	  0.001)	  associated	  with	  positive	  influences	  towards	  self-­‐efficacy	  and	  empowerment	  to	  change	  negative	  health	  behaviors	  (p<0.001).	  	  Miller	  and	  Spilker	  (2003)	  found	  that	  Brief	  Intervention	  (BI)	  group	  had	  higher	  mean	  scores	  over	  the	  simple	  advice	  and	  control	  groups.	  The	  BI	  group	  scored	  significantly	  higher	  in	  the	  following	  areas:	  	  initiated	  and	  achieved	  stroke-­‐risk	  reduction	  behaviors	  (p=0.005);	  knowledge	  of	  stroke	  symptoms	  (p=0.001);	  and	  major	  risk	  factors	  (p=0.01).	  	  Hwang	  et	  al.,	  2010,	  found	  after	  assessing	  stroke	  knowledge	  and	  retention	  of	  both	  intervention	  groups	  closed-­‐end	  questions	  (recognition)	  and	  open-­‐ended	  questions	  
	  	   12	  
(recall)	  that	  the	  mean	  score	  of	  recognition	  group	  was	  significantly	  higher	  than	  that	  of	  the	  recall	  group	  at	  each	  test	  (p<0.001).	  	  Silver	  et	  al.,	  2003,	  found	  a	  significant	  increase	  in	  ability	  to	  name	  >	  2	  warning	  signs	  of	  stroke	  in	  the	  community	  when	  receiving	  television	  advertising	  whether	  at	  an	  intermittent	  low-­‐level	  or	  continuous	  high	  level	  versus	  print	  advertising.	  	  At	  follow-­‐up	  Silver	  et	  al.,	  (2003),	  found	  no	  significant	  change	  in	  the	  print	  group,	  except	  for	  those	  >	  65	  years	  of	  age	  and	  a	  decrease	  in	  the	  control	  group	  at	  follow	  up	  (Silver	  et	  al.,	  2003).	  	  	   Even	  though	  some	  educational	  tools	  showed	  improvement,	  no	  single	  educational	  tool	  appeared	  to	  be	  ideal	  for	  the	  diversity	  of	  all	  populations.	  	  A	  lack	  of	  generalizability	  by	  using	  a	  convenience	  sample	  was	  noted	  as	  a	  limitation	  for	  four	  of	  the	  studies	  (Davis	  et	  al.,	  2009;	  Miller	  et	  al.,	  2007;	  Miller	  &	  Spilker,	  2003;	  Hwang	  et	  al.,	  2010).	  Furthermore,	  the	  need	  for	  protracted	  study	  lengths	  to	  evaluate	  knowledge	  retention	  is	  a	  notable	  limitation.	  
Cultural	  and	  Socioeconomic	  Findings.	  	   Boden-­‐Albala	  et	  al.	  (2010)	  compared	  culturally	  tailored,	  interactive	  stroke	  education	  with	  standard	  of	  care	  educational	  handouts	  and	  recorded	  time	  from	  symptom	  onset	  to	  ED	  arrival:	  the	  mean	  was	  46	  hours	  and	  the	  median	  was	  12.9	  hours.	  	  This	  time	  to	  ED	  arrival	  differed	  among,	  Black,	  Hispanic,	  and	  White	  populations.	  	  Hispanics	  had	  the	  lowest	  arrival	  time	  of	  the	  three	  groups	  (mean	  39h,	  median	  11h).	  	  Blacks	  and	  Whites	  were	  similar	  with	  a	  mean	  arrival	  time	  of	  52	  hours.	  	  Educational	  level	  differed	  among	  these	  three	  race-­‐ethnicities.	  	  Whites	  were	  found	  about	  one-­‐third	  more	  likely	  to	  finish	  high	  school	  (92%)	  than	  Blacks	  (64%)	  and	  two-­‐thirds	  more	  likely	  than	  Hispanic	  participants	  (32%)	  (p<0.000).	  	  This	  translated	  to	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the	  overall	  mean	  baseline	  stroke	  knowledge	  score	  of	  71%	  (Boden-­‐Albala	  et	  al.,	  2010).	  	  Whites	  scored	  the	  highest	  at	  (77%	  mean	  and	  79%	  median),	  Blacks	  were	  second	  (70%	  mean	  and	  71%	  median),	  and	  Hispanics	  the	  lowest	  (69%	  mean	  and	  70%	  median)	  (p<0.01).	  	  Discrepancies	  in	  education	  and	  race	  must	  be	  taken	  into	  consideration	  when	  developing	  educational	  tools.	  	  	  	   Das	  and	  associates	  (2007)	  showed	  the	  average	  time	  to	  arrive	  at	  ED	  after	  stroke	  was	  34	  +/-­‐	  6	  hours.	  The	  arrival	  time	  to	  ED	  after	  onset	  of	  stroke	  was	  influenced	  by	  education,	  socioeconomic	  status,	  history	  of	  stroke,	  and	  the	  advice	  of	  friends	  and	  local	  doctors.	  	  The	  least	  educated	  healthy	  people	  and	  stroke	  patients	  had	  the	  lowest	  level	  of	  knowledge	  regarding	  risk	  factors	  and	  warning	  signs	  of	  stroke	  (Das	  et	  al.,	  2007).	  	  Age	  was	  also	  a	  factor	  in	  decreased	  awareness/knowledge	  of	  stroke.	  	  Hickey	  et	  al.,	  (2009),	  found	  that	  there	  was	  a	  decrease	  in	  knowledge	  among	  the	  elderly,	  especially	  in	  those	  with	  only	  a	  primary	  education	  and	  living	  within	  a	  rural	  community.	  Mass	  media	  (television)	  was	  the	  number	  one	  cited	  source	  of	  knowledge	  when	  the	  pubic	  was	  interviewed	  regarding	  stroke	  knowledge	  (Schneider	  et	  al.,	  2003).	  	  	  	   In	  summary,	  there	  is	  limited	  general	  knowledge	  of	  stroke.	  	  Factors	  of	  race,	  educational	  level,	  socioeconomic	  status,	  and	  culture	  affect	  stroke	  knowledge.	  	  It	  is	  important	  to	  understand	  these	  limitations	  so	  stroke	  awareness	  can	  be	  increased,	  warning	  signs	  can	  be	  recognized	  earlier	  and	  arrival	  times	  to	  ED	  shortened.	  	  Effective,	  culturally	  and	  racially	  relevant	  educational	  interventions	  and	  reinforcements	  are	  invaluable	  contributors	  in	  affecting	  modifiable	  risk	  factors	  and	  improving	  stroke	  awareness.	  	  These	  studies	  have	  shown	  that:	  (a)	  discrepancies	  in	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education	  and	  race	  must	  be	  taken	  into	  consideration	  when	  developing	  educational	  tools;	  (b)	  programs	  for	  stroke	  education	  and	  awareness	  should	  be	  utilized	  as	  early	  as	  possible;	  (c)	  television	  yields	  higher	  awareness	  than	  print	  advertisement;	  and	  (d)	  recognition	  questions	  have	  better	  scores	  than	  recall	  questions	  on	  stroke	  knowledge	  retention.	  	   	   	   	   	   	   	   	   	   	   	  
Gap	  Analysis	  	   The	  incidence	  of	  stroke	  remains	  high	  despite	  evidence-­‐based	  advances	  in	  prevention	  and	  treatment.	  	  	  Each	  study	  in	  this	  review	  found	  a	  wide	  gap	  between	  what	  is	  known	  about	  risk	  factors	  in	  ischemic	  stroke	  and	  individual	  awareness.	  Basic	  information	  available	  to	  the	  public	  on	  the	  basis	  of	  evidence-­‐based	  medical	  guidelines	  is	  lacking.	  	  Although	  stroke	  knowledge	  deficiency	  was	  more	  prevalent	  in	  adolescence,	  elderly,	  lower	  socioeconomic	  status,	  minority	  races,	  and	  those	  only	  receiving	  a	  high	  school	  education	  or	  less;	  this	  lack	  of	  knowledge	  about	  general	  risk	  factors	  was	  evident	  in	  all	  groups	  regardless	  of	  age,	  gender,	  or	  ethnicity.	  Nevertheless,	  the	  inability	  to	  disseminate	  critical	  information	  to	  individuals	  in	  a	  form	  that	  is	  accessible,	  understood,	  internalized	  and	  results	  in	  improved	  health	  care	  habits	  limits	  the	  ability	  of	  evidence-­‐based	  medicine	  to	  affect	  stroke	  occurrence	  and	  treatment.	  	   	   	   	   	   	   	   	   	   	  	   In	  2010,	  the	  annual	  costs	  of	  ischemic	  cerebrovascular	  disease	  and	  the	  related	  cost	  of	  disability	  and	  loss	  of	  production	  in	  the	  United	  States	  exceeded	  $73.7	  billion	  (ASA,	  2012).	  	  The	  vast	  majority	  of	  these	  events	  potentially	  can	  be	  prevented	  if	  translation	  of	  evidence	  denoting	  specific	  risk	  factors	  can	  be	  successfully	  made	  to	  healthcare	  professionals	  and	  the	  public	  at	  large.	  	  Finding	  an	  accurate	  and	  efficacious	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educational	  tool	  is	  critical	  to	  reduction	  in	  stroke	  occurrence	  and	  healthcare	  expenditures.	  Knowledge	  is	  powerless	  if	  unable	  to	  be	  applied.	  
Conclusion	  and	  Recommendations	  for	  Evidence-­Based	  Practice	  
	   The	  factors	  influencing	  the	  incidence	  of	  stroke	  occurrence	  and	  pre-­‐hospital	  delay	  in	  seeking	  treatment	  are	  related	  primarily	  to	  failures	  in	  patient	  knowledge	  of	  risk	  factors	  and	  recognition	  of	  stroke	  symptoms	  (Boden-­‐Albala	  et	  al.,	  2010;	  Das	  et	  al.,	  2007).	  Although	  evidence-­‐based	  guidelines	  for	  identification	  and	  treatment	  of	  stroke	  risk	  factors	  have	  been	  published,	  dissemination	  of	  this	  information	  into	  the	  public	  sphere	  has	  been	  lacking.	  	  Indeed,	  as	  this	  review	  demonstrates,	  the	  appropriate	  and	  successful	  educational	  medium(s)	  to	  impart	  this	  information	  remains	  problematic.	  	  These	  studies	  ask	  more	  than	  they	  offer.	  	  The	  studies	  demonstrated:	  (a)	  public	  awareness	  of	  stroke	  is	  lacking;	  (b)	  educational	  tools	  used	  are	  inadequate;	  and	  (c)	  education	  may	  be	  more	  effective	  when	  delivered	  at	  an	  early	  age	  (Boden-­‐Albala	  et	  al.,	  2010;	  Miller	  &	  Spilker,	  2003;	  Davis	  et	  al.,	  2009;	  Hickey,	  O’Hanlon,	  McGee,	  et	  al.,	  2009;	  Schneider,	  Pancioli,	  Khoury,	  et	  al.,	  2003).	  	  Although	  the	  theory	  may	  be	  valid	  that	  education	  can	  be	  a	  factor	  in	  reducing	  the	  incidence	  of	  stroke,	  these	  collective	  studies	  indicate	  the	  proper	  methodology	  for	  imparting	  that	  knowledge	  to	  the	  community	  at-­‐large	  remains	  to	  be	  explored	  and	  established.	  	  The	  educational	  intervention	  that	  is	  most	  effective	  is	  intense	  individual	  counseling	  and	  if	  possible	  at	  an	  early	  age	  (Miller&Spilker,	  2003;	  Miller	  et	  al.,	  2007).	  	  Generic	  public	  educational	  tools,	  e.g.,	  written	  materials,	  surveys	  and	  posters,	  are	  much	  less	  effective	  and	  limited	  in	  scope	  (Davis	  et	  al.,	  2009).	  	  A	  much	  broader,	  mass	  media	  approach	  is	  also	  necessary	  to	  successfully	  accomplish	  a	  reduction	  in	  stroke	  rate	  and	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improve	  acute	  interventions	  (Silver	  et	  al.,	  2003).	  	  Any	  educational	  tool	  must	  be	  predicated	  on	  a	  thorough	  evidence-­‐based	  knowledge	  of	  stroke	  as	  well	  as	  an	  understanding	  of	  the	  socio-­‐economical	  and	  psychological	  environment,	  contingent	  attitudes,	  opinions,	  and	  behavioral	  patterns	  of	  the	  targeted	  audience.	  	  The	  mass-­‐media	  ability	  of	  television	  offers	  a	  possibility	  to	  fulfill	  these	  requirements.	  	  	   	  	   Educational	  programs	  must	  be	  designed	  to	  address	  all	  aspects	  of	  stroke	  risk	  factors,	  signs	  and	  symptoms	  and	  necessity	  for	  emergent	  treatment	  specifically	  targeted	  to	  diverse	  cultures	  and	  age	  groups.	  	  The	  key	  will	  be	  to	  work	  within	  the	  configuration	  of	  the	  community	  to	  develop	  educational	  tool(s)	  that	  are	  consistent	  with	  the	  morals,	  habits,	  and	  culture	  of	  the	  individual	  and	  the	  entire	  community.	   	  	   The	  goal	  for	  stroke	  prevention	  is	  to	  increase	  awareness	  and	  change	  behavior	  towards	  risk	  factors	  associated	  with	  occurrence	  and	  increase	  access	  to	  stroke	  treatments	  for	  all	  eligible	  patients.	  	  To	  achieve	  this	  aim,	  we	  need	  to	  change	  people’s	  awareness	  of	  and	  behavior	  to	  stroke	  symptoms	  by	  concentrating	  efforts	  toward	  developing	  mass-­‐media	  educational	  tools	  for	  all.	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(NGC,	  2010)	  *Davis	  et	  al.	  (2009)	  
	  
Qualitative:	  Single	  blinded,	  randomized,	  pretest,	  posttest,	  prospective	  study,	  using	  two	  age	  cohorts	  	  Extended	  Parallel	  Process	  Model	  
Convenience	  Sampling	  	  274	  participants	  of	  Morgantown,	  West	  Virginia;	  of	  2	  age	  cohorts:	  younger	  (18-­‐30	  years	  of	  age)	  and	  older	  (50+	  years)	  
IV:	  Stroke	  Poster	  DV:	  Public	  Awareness	  and	  information	  retention	  of	  stroke	  
To	  assess	  the	  comparative	  effect	  on	  public	  awareness	  and	  information	  retention	  by	  using	  a	  standard	  stroke	  education	  poster	  and	  a	  standard	  education	  poster	  modified	  by	  the	  health	  communications	  model	  of	  Extended	  Parallel	  Process.	  
Posters	  whether	  modified	  or	  not	  are	  not	  good	  educational	  tools	  for	  stroke	  awareness	  	  Did	  not	  significantly	  improve	  the	  knowledge	  and	  retention	  of	  s/s	  of	  stroke	  	  Young	  better	  than	  old	  but	  that	  is	  limited	  to	  the	  number	  of	  elderly	  participants	  
Non-­‐significant	  trend	  towards	  gained	  knowledge	  and	  retention	  with	  participants	  viewing	  the	  modified	  poster.	  	  Both	  groups	  showed	  improvement	  from	  baseline	  knowledge,	  but	  overall	  insignificant.	  	  Posters	  not	  good	  educational	  tools	  for	  stroke	  awareness	  and	  retention.	  Other	  educational	  tools	  needed	  to	  improve	  stroke	  awareness	  and	  raise	  retention	  of	  awareness.	  	  
	  
Level	  1	  RCT	  	  Grade	  A	  Directly	  applicable	  to	  the	  target	  population,	  and	  demonstrating	  overall	  consistency	  of	  result	  
*Boden-­‐Albala	  et	  al.	  (2010)	   Quantitative:	  Longitudinal,	  randomized	  control	  trial	  in	  a	  multi-­‐ethnic	  cohort	  	  Social-­‐ecological	  framework	  
Purposive	  Sampling	  	  736	  patients	  of	  Columbia	  University	  Medical	  Center	  who	  have	  had	  a	  stroke	  or	  TIA	  and	  are:	  >Over	  18	  years	  of	  age	  >Living	  in	  a	  household	  with	  a	  telephone	  
IV:	  Swift	  Educational	  Strategy	  	  DV:	  Stroke	  Knowledge	  	  
To	  determine	  whether	  a	  culturally	  	  Tailored,	  interactive	  educational	  program	  in	  a	  racially	  and	  ethnically	  diverse	  high	  risk	  population	  aimed	  at	  stroke	  awareness	  and	  emergency	  treatment	  will	  lead	  to	  increased	  knowledge,	  behavioral	  change,	  and	  improved	  
Clear-­‐cut	  race	  discrepancy	  in	  knowledge	  of	  symptoms	  and	  possible	  intervention	  of	  stroke.	  	  Educational	  level	  differed	  by	  race-­‐	  ethnicity.	  Whites	  had	  higher	  knowledge	  scores	  regarding	  strokes	  than	  Blacks	  or	  Hispanics.	  	  
The	  overall	  mean	  time	  from	  symptom	  onset	  to	  ED	  arrival	  was	  46-­‐hours,	  median	  12.9	  hours	  Hispanics	  –	  mean	  39h/median	  11h	  Whites	  –	  52h/11h	  Blacks	  –	  52h/17h	  (p<0.03)	  	  The	  overall	  mean	  baseline	  “stroke	  knowledge	  was	  
Level	  1	  RCT	  	  Grade	  A	  Directly	  applicable	  to	  the	  target	  population,	  and	  demonstrating	  overall	  consistency	  of	  results	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arrival	  time	  to	  the	  ED	  upon	  onset	  of	  stroke	  symptoms.	  
71%,	  	  median	  71%	  	  White:	  77%,79%	  Blacks:	  70%,71%	  Hispanics:	  69%,70%	  *Miller	  et	  al.	  (2007)	   Quantitative:	  Experimental	  prospective,	  pretest,	  posttest	  format	  	  	  Underpinnings	  of	  the	  Social	  Cognitive	  Theory	  	  	  
Convenience	  Sampling	  	  72	  Students	  with	  the	  mean	  age	  of	  13.25	  
IV:	  FAST	  Stroke	  Prevention	  Educational	  Program	  DV:	  Awareness	  of	  stroke	  signs	  and	  symptoms,	  risk	  factors,	  and	  risk	  factor	  reduction	  
	  
To	  evaluate	  the	  effects	  of	  FAST	  Stroke	  Prevention	  Educational	  Program	  for	  middle	  school	  students.	  To	  improve	  awareness	  of	  stroke	  signs	  and	  symptoms,	  risk	  factors,	  and	  risk	  factor	  reduction.	  
Significant	  increase	  in	  knowledge	  in	  young	  people.	  	  Improved	  knowledge	  of	  stroke	  warning	  signs	  and	  risk	  factors	  of	  stroke.	  	  	  Positive	  influence	  towards	  self-­‐efficacy	  and	  empowerment	  	  to	  change	  negative	  health	  behaviors.	  	  	  FAST	  mnemonic	  recall	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Programs	  for	  stroke	  education	  and	  awareness	  should	  be	  a	  life	  long	  tool	  	  Populations	  and	  communities	  at	  an	  early	  age	  can	  be	  affected	  	  Educational	  tools	  for	  strokes	  should	  be	  directed	  as	  early	  as	  possible	  	  Necessity	  for	  continued	  research	  in	  the	  younger	  populations	  for	  stroke	  awareness	  and	  retention	  
Level	  2	  Well	  conducted	  case	  control	  or	  cohort	  studies	  with	  a	  low	  risk	  of	  confounding	  or	  bias	  and	  a	  moderate	  probability	  that	  the	  relationship	  is	  causal	  	  Grade	  C	  directly	  applicable	  to	  the	  target	  population	  and	  demonstrating	  overall	  consistency	  of	  results;	  
*Miller	  &	  Spilker	  (2003).	  	  
Quantitative:	  Prospective,	  experimental	  Design	  of	  a	  repeated	  measures	  design	  that	  had	  three	  groups:	  control,	  advice,	  and	  brief	  educational	  intervention.	  	  Brief	  Intervention	  Model	  linked	  with	  the	  Stage	  of	  Readiness	  to	  Change	  
Convenience/Purposive	  Sampling	  	  60	  patients	  from	  a	  university	  family	  practice	  center	  who	  were	  able	  to	  coherently	  speak	  English,	  had	  a	  score	  of	  >	  	  8	  on	  the	  10-­‐item	  Short	  Portable	  Mental	  Status	  Exam,	  could	  not	  identify	  all	  four	  stroke	  symptoms,	  
IV:	  educational	  strategy	  of	  Brief	  Intervention	  	  DV:	  readiness	  to	  initiate	  behaviors	  to	  reduce	  stroke.	  
To	  determine	  whether	  (a)	  patients	  at	  risk	  for	  stroke	  in	  one	  of	  three	  groups	  have	  differences	  in	  the	  number	  of	  newly	  initiated	  and	  achieved	  behaviors	  to	  reduce	  their	  stroke	  risk;	  (b)	  patients	  at	  risk	  for	  stroke	  have	  differences	  in	  the	  umber	  of	  identified	  stroke	  symptoms,	  major	  stroke	  risk	  factors,	  or	  description	  of	  treatment	  –
75%	  of	  participants	  who	  were	  evaluated	  by	  the	  NSA	  Stroke	  Risk	  Appraisal	  at	  being	  at	  risk	  for	  stroke	  had	  never	  been	  told	  so	  by	  their	  healthcare	  provider.	  	  BI	  group	  had	  a	  higher	  success	  rate	  in	  behavior	  changes	  for	  reducing	  stroke-­‐risks	  and	  increasing	  their	  
The	  BI	  group	  had	  a	  significantly	  higher	  number	  of	  newly	  initiated	  and	  achieved	  preventative	  stroke-­‐risk-­‐reduction	  behaviors	  compared	  to	  the	  other	  two	  groups.	  	  The	  BI	  group	  had	  the	  greatest	  positive	  change	  from	  pre-­‐test	  to	  post-­‐test	  regarding	  knowledge	  of	  stroke	  
Level	  1	  Well-­‐conducted	  meta-­‐analyses,	  systematic	  reviews	  of	  RCTs,	  or	  RCTs	  with	  a	  low	  risk	  of	  bias.	  	  Grade	  A	  A	  body	  of	  evidence	  consisting	  principally	  of	  studies	  rated	  as	  1+,	  directly	  applicable	  to	  the	  target	  population,	  and	  demonstra-­‐ting	  overall	  consistency	  of	  results	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could	  not	  correctly	  state	  the	  major	  stroke	  –	  risk	  factors,	  and	  were	  identified	  as	  at	  risk	  	  for	  stroke	  by	  their	  medical	  history.	  
seeking	  behavior	  when	  a	  stroke	  is	  suspected;	  and	  (c)	  a	  patient’s	  age,	  readiness	  to	  change,	  perceived	  health	  status,	  functional	  status,	  martial	  status,	  quality	  of	  life,	  or	  level	  of	  depression	  influence	  the	  initiation	  of	  behaviors	  to	  reduce	  stroke	  or	  increase	  knowledge	  of	  stroke	  warning	  signs	  or	  risk	  factors.	  
knowledge	  of	  stroke	  awareness.	   symptoms,	  major	  risk-­‐factors,	  and	  treatment-­‐seeking	  behaviors.	  	  Nurses	  along	  with	  effective	  educational	  reinforcements	  such	  as	  BI	  are	  an	  invaluable	  contribution	  in	  reducing	  modifiable	  risk	  factors	  and	  improving	  stroke-­‐related	  knowledge.	  	  Relationships	  pertaining	  to	  race,	  spirituality,	  and	  behavior	  achievement	  need	  to	  be	  more	  closely	  studied	  in	  future	  research	  pertaining	  to	  the	  BI	  process.	  Das	  et	  al.	  (2007)	   Qualitative:	  Cross-­‐sectional	  	  	  No	  conceptual	  framework	  identified	  	  
Purposive	  Sampling	  	  	  660	  stroke	  patients	  discharged	  from	  Burdwan	  Medical	  College	  and	  Hospital	  and	  4,000	  healthy	  people	  from	  the	  general	  population	  who	  accompanied	  the	  patients.	  
N/A	   To	  evaluate	  general	  awareness	  of	  the	  risk	  factors	  for	  stroke,	  as	  well	  as	  the	  associated	  symptoms,	  to	  plan	  a	  public	  educational	  program	  to	  reduce	  the	  incident	  of	  stroke	  and	  to	  improve	  stroke	  care.	  
Arrival	  time	  to	  ED	  after	  onset	  of	  stroke	  and	  stroke	  knowledge	  are	  influenced	  by	  education,	  socio-­‐economic	  status,	  history	  of	  stroke,	  and	  the	  advice	  of	  friends	  and	  local	  doctors.	  	  
Average	  time	  to	  ED	  after	  stroke	  was	  34	  +/-­‐	  6	  hours.	  	  Limited	  knowledge	  of	  stroke	  s/s	  	  Less	  educated	  people	  and	  stroke	  patients	  had	  the	  lowest	  level	  of	  knowledge	  regarding	  risk	  factors	  and	  warning	  signs	  of	  stroke	  	  Important	  to	  increase	  awareness	  so	  that	  warning	  symptoms	  are	  recognized	  earlier	  and	  arrival	  times	  to	  
Level	  3	  Non-­‐analytic	  studies	  	  Grade	  D	  Evidence	  level	  3	  or	  4	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ED	  are	  shortened.	  Hickey	  et	  al.	  (2009)	   Quantitative	  Cross-­‐	  sectional	  Survey	  	  	  No	  conceptual	  Framework	  identified	  
Convenience	  Sampling	  	  2,033	  Randomly	  selected	  community-­‐dwelling	  older	  people	  (65+	  years)	  in	  Ireland.	  
N/A	   To	  examine	  knowledge	  of	  stroke	  warning	  signs	  and	  risk	  factors	  among	  community-­‐	  dwelling	  older	  adults.	  
Less	  than	  half	  of	  the	  sample	  could	  identify	  stroke	  risk	  factors	  and/or	  stroke	  warning	  signs.	  	  Lack	  of	  stroke	  awareness	  was	  higher	  in	  the	  elderly	  and	  even	  more	  so	  in	  the	  population	  with	  only	  a	  primary	  education	  and	  living	  in	  a	  rural	  community.	  
Vital	  time	  will	  be	  lost	  for	  medical	  intervention	  due	  to	  the	  lack	  of	  knowledge	  regarding	  stroke.	  
Level	  3	  Non-­‐analytic	  studies	  	  Grade	  C	  Evidence	  is	  from	  outcomes	  of	  uncontrolled	  or	  nonrandom-­‐mized	  trials	  or	  from	  observational	  studies.	  	  
*Hwang	  et	  al.	  (2010)	  	   Quantitative:	  Experimental	  prospective,	  pretest,	  posttest	  format	  	  	  	  	  No	  conceptual	  framework	  identified.	  	  
Convenience	  Sample	  	  138	  college	  students	  at	  a	  university	  in	  Taiwan	  
IV:	  Educational	  Intervention	  DV:	  	  Closed-­‐ended	  or	  open-­‐ended	  questionnaire	  group	  
To	  investigate	  undergraduate	  awareness	  about	  stroke	  and	  examine	  whether	  educational	  videos	  and	  a	  series	  of	  lectures	  would	  increase	  knowledge	  of	  stroke.	  The	  students	  were	  divided	  into	  two	  groups	  and	  closed-­‐	  ended	  questionnaires	  and	  open0ended	  questionnaires	  were	  compared	  at	  pretest	  and	  posttest	  to	  evaluate	  which	  testing	  method	  attributed	  higher	  scores.	  	  	  
The	  mean	  score	  of	  the	  recognition	  group	  was	  significantly	  higher	  than	  that	  of	  the	  recall	  group.	  	  
Large	  knowledge	  deficit	  in	  stroke	  signs	  and	  symptoms	  and	  stroke	  risk	  factors	  in	  undergraduate	  students.	  	  Educational	  interventions	  can	  significantly	  improve	  knowledge	  towards	  stroke.	  
Level	  2	  Well	  conducted	  case	  control	  or	  cohort	  studies	  with	  a	  low	  risk	  of	  confounding	  or	  bias	  and	  a	  moderate	  probability	  that	  the	  relationship	  is	  causal	  	  Grade	  B	  Evidence	  is	  from	  endpoints	  of	  intervention	  studies	  that	  include	  only	  a	  limited	  number	  of	  patients	  
*Silver	  et	  al.	  (2003)	  	   Quantitative:	  Cross-­‐sectional	  survey	  	  	  	  	  No	  conceptual	  framework	  
Convenience	  Sampling	  	  Members	  of	  one	  of	  four	  communities	  >	  45	  year	  years	  of	  age	  living	  in	  Ontario.	  	  
IV:	  mass	  media	  educational	  stroke	  programs	  DV:	  Stroke	  awareness	  
To	  examine	  the	  effect	  of	  mass	  media	  as	  an	  educational	  intervention	  to	  increase	  stroke	  awareness.	  	  
Television	  advertising	  significantly	  increased	  stroke	  awareness	  in	  both	  men	  and	  women,	  and	  people	  of	  with	  less	  than	  a	  
Television	  effectiveness	  proven	  to	  increase	  stroke	  awareness,	  but	  unknown	  if	  this	  will	  translate	  to	  a	  change	  in	  behavior	  and	  more	  timely	  
Level	  2	  Well	  conducted	  case	  control	  or	  cohort	  studies	  with	  a	  low	  risk	  of	  confounding	  or	  bias	  and	  a	  moderate	  probability	  that	  the	  relationship	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identified.	  	   n=	  3,133	  	  	  	  	  	  	  	  	  
secondary	  level	  of	  education,	  but	  not	  those	  >	  65	  years	  of	  age.	  	  
arrival	  time	  to	  ED.	   is	  causal	  	  Grade	  B	  Directly	  applicable	  to	  the	  target	  population,	  and	  demonstra-­‐ting	  overall	  consistency	  of	  results	  Schneider	  et	  al.	  (2003)	  	   Quantitative:	  Population	  based	  random	  telephone	  survey.	  	  	  	  	  No	  conceptual	  framework	  identified	  
Convenience	  Sampling:	  	  2173	  randomly	  selected	  from	  all	  residents	  in	  a	  5-­‐county	  region	  around	  Cincinnati,	  OH.	  
N/A	   To	  examine	  temporal	  trends	  in	  public	  knowledge	  of	  stroke	  warning	  signs	  and	  risk	  factors.	  
70%	  of	  respondents	  correctly	  named	  at	  least	  1	  established	  stroke	  warning	  signed	  compared	  to	  the	  poll	  conducted	  in	  1995	  at	  57%.	  Television	  was	  also	  cited	  as	  the	  most	  frequent	  source	  of	  knowledge.	  
Public	  awareness	  is	  not	  at	  a	  desirable	  level	  especially	  in	  at	  risk	  populations.	  Continued	  focus	  towards	  stroke	  awareness	  needs	  direction	  towards	  at	  risk	  populations.	  	  Since	  television	  is	  most	  frequently	  cited	  as	  a	  source	  of	  stroke	  information,	  campaigns	  should	  be	  targeted	  towards	  mass	  media	  approaches.	  
Level	  3	  Non-­‐analytic	  studies	  	  Grade	  D	  Evidence	  level	  3	  or	  4	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Scope	  and	  Practice	  Stroke	  is	  currently	  one	  of	  the	  leading	  causes	  of	  death	  worldwide.	  	  	  Ongoing	  research	  has	  focused	  on	  ways	  to	  reduce	  the	  incidence	  and	  mortality	  rates	  associated	  with	  this	  condition.	  	  Through	  past	  research	  it	  was	  discovered	  that	  stroke	  was	  more	  prevalent	  in	  the	  female	  population.	  	  As	  a	  result	  of	  these	  findings,	  a	  focus	  has	  currently	  been	  placed	  on	  assessing	  stroke	  risk	  factors	  and	  prevention	  strategies	  in	  women.	  	  The	  purpose	  of	  this	  paper	  is	  to	  use	  a	  modified	  version	  of	  the	  Appraisal	  of	  Guidelines	  for	  Research	  and	  Evaluation	  (AGREE)	  Instrument	  (2001)	  to	  analyze	  the	  guideline	  written	  by	  the	  American	  Heart	  Association	  and	  the	  American	  Stroke	  Association	  regarding	  prevention,	  detection,	  evaluation	  and	  treatment	  of	  stroke	  in	  women.	  	  The	  Guideline	  for	  the	  Prevention	  of	  Stroke	  in	  Women	  (Bushnell	  et	  al.,	  2014)	  provides	  evidenced-­‐based	  recommendations	  for	  all	  healthcare	  providers	  regarding	  the	  recognition	  and	  management	  of	  stroke	  risk	  factors	  that	  are	  specific	  to	  or	  more	  common	  in	  women.	  	  The	  guideline	  was	  published	  in	  the	  American	  Heart	  Association	  journal	  Stroke.	  	  Cerebrovascular	  infarct	  or	  hemorrhage	  (stroke)	  is	  the	  fourth	  leading	  cause	  of	  death	  and	  one	  of	  the	  most	  common	  causes	  of	  adult	  disability	  in	  the	  United	  States.	  It	  is	  currently	  the	  second	  leading	  cause	  of	  death	  worldwide	  (Centers	  for	  Disease	  Control,	  2013;	  National	  Institute	  of	  Neurological	  Disorders	  and	  Stroke,	  2013;	  World	  Health	  Organization,	  2013).	  	  By	  2020,	  stroke	  will	  become	  the	  leading	  cause	  of	  death	  and	  disability	  worldwide	  (WHO,	  2004).	  	  	  Stroke	  results	  from	  a	  disruption	  of	  the	  blood	  supply	  to	  the	  brain.	  	  Loss	  of	  blood	  supply	  secondary	  to	  a	  circulatory	  vessel	  occlusion	  results	  in	  a	  cascade	  of	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events,	  ultimately	  leading	  to	  loss	  of	  brain	  tissue	  and	  function.	  Persons	  sustaining	  a	  stroke	  may	  experience	  loss	  of	  movement	  and/or	  ability	  to	  perceive	  sensation,	  inability	  to	  speak	  or	  understand,	  and/or	  loss	  of	  vision.	  	  On	  average	  795,000	  new	  cases	  of	  strokes	  or	  recurrent	  strokes	  occur	  annually	  within	  the	  United	  States,	  with	  approximately	  160,000	  of	  these	  resulting	  in	  death	  (American	  Stroke	  Association,	  2012;	  NINDS,	  2013).	  	  	   In	  2009,	  strokes	  accounted	  for	  5%	  (5th	  leading	  cause)	  of	  all	  deaths	  in	  Kentucky,	  and	  the	  state	  was	  ranked	  11th	  nationally	  for	  stroke	  mortality	  rates	  (American	  Heart	  Association,	  2013;	  Kentucky	  Cabinet	  of	  Health	  and	  Family	  Services,	  2014).	  	  Residents	  of	  Kentucky	  are	  highly	  susceptible	  to	  stroke	  by	  living	  within	  the	  “stroke	  belt”,	  which	  places	  them	  at	  higher	  risk	  for	  contributing	  stroke	  risk	  factors.	  (Liao,	  Greenlund,	  Croft,	  Keenan	  &	  Giles,	  2009).	  	  (See	  Appendix	  A)	  The	  stroke	  belt	  consists	  of	  the	  following	  states:	  	  Alabama,	  Arkansas,	  Georgia,	  Indiana,	  Kentucky,	  Louisiana,	  Mississippi,	  North	  Carolina,	  South	  Carolina,	  Tennessee,	  and	  Virginia	  (Liao	  et	  al.,	  2009).	  	  When	  states	  within	  the	  stroke	  belt	  were	  compared	  to	  states	  outside	  of	  the	  stroke	  belt	  factors	  such	  as	  socioeconomic	  status,	  race/ethnicity,	  and	  education	  of	  the	  representative	  populations	  were	  found	  to	  correlate	  with	  stoke	  prevalence.	  	  	  These	  cultural	  indicators	  often	  associated	  with	  an	  increased	  prevalence	  of	  other	  stroke	  specific	  risk	  factors	  such	  as	  obesity,	  smoking,	  hypertension,	  diabetes,	  and	  coronary	  heart	  disease	  (Liao	  et	  al.,	  2009).	  	   It	  has	  been	  estimated	  that	  up	  to	  80%	  of	  strokes	  are	  preventable	  by	  controlling	  risk	  factors	  (NINDS,	  2013).	  	  The	  risks	  of	  suffering	  a	  stroke	  may	  be	  either	  modifiable	  or	  non-­‐modifiable.	  	  Some	  of	  the	  major	  modifiable	  risk	  factors	  include	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hypertension,	  tobacco	  abuse,	  dyslipidemia,	  and	  glucose	  intolerance.	  	  Non-­‐modifiable	  risk	  factors	  for	  stroke	  are	  age,	  genetics,	  race,	  and	  gender	  (ASA,	  2012).	  	  	  	   Female	  gender	  is	  a	  non-­‐modifiable	  stroke	  risk	  factor.	  	  Stroke	  is	  the	  third	  leading	  killer	  of	  all	  women	  in	  the	  United	  States,	  and	  the	  fourth	  leading	  cause	  in	  men	  (AHA/ASA,	  2014;	  CDC,	  2013).	  	  Women	  suffer	  from	  55,000	  more	  strokes	  annually,	  and	  die	  from	  strokes	  more	  often	  than	  men	  each	  year	  (AHA/ASA,	  2014).	  	  Some	  of	  the	  stroke	  risk	  factors	  that	  are	  exclusive	  to	  women	  or	  affect	  women	  more	  often	  than	  men	  are	  as	  follows:	  pregnancy	  and	  preeclampsia,	  oral	  contraceptive	  use,	  hormone	  replacement	  therapy,	  migraines	  with	  auras,	  metabolic	  syndrome,	  and	  atrial	  fibrillation	  (AHA/ASA,	  2014).	  	  	  	   In	  addition	  to	  the	  often-­‐devastating	  consequences	  of	  stroke	  in	  women	  there	  are	  financial	  implications	  to	  consider.	  	  In	  2010,	  the	  annual	  costs	  of	  ischemic	  cerebrovascular	  disease	  and	  the	  related	  cost	  of	  disability	  and	  loss	  of	  production	  in	  the	  United	  States	  exceeded	  $73.7	  billion	  (ASA,	  2012).	  	  	  As	  the	  population	  ages	  so	  does	  the	  economic	  impact	  of	  presiding	  health	  disparities,	  especially	  stroke.	  	  In	  2010,	  stroke-­‐related	  hospitalizations	  cost	  the	  state	  of	  Kentucky	  over	  $329	  million	  (KCHFS,	  2014).	  The	  evolution	  and	  consequences	  of	  these	  findings	  warrant	  evaluation	  to	  provide	  practitioners	  with	  a	  guideline	  to	  aid	  prevention	  of	  first	  stroke	  in	  women.	  	  In	  conglomeration	  with	  early	  recognition	  and	  intervention,	  the	  potential	  for	  stroke	  may	  be	  deferred	  through	  modifiable	  risk	  factors	  such	  as	  hypertension,	  glycemic	  control,	  and	  smoking	  cessation.	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Stakeholder	  Involvement	  	  	   The	  stakeholders	  involved	  in	  the	  creation	  of	  this	  guideline	  are	  numerous.	  	  For	  several	  decades	  the	  American	  College	  of	  Cardiology	  (ACC)	  and	  the	  American	  Heart	  Association	  (AHA)	  have	  partnered	  together	  to	  make	  the	  highest	  quality	  evidence	  based	  guidelines	  for	  healthcare	  professional	  on	  topics	  of	  cardiovascular	  disease	  and	  stoke	  (AHA,	  2010).	  	  These	  two	  bodies	  have	  published	  many	  scientific	  works	  along	  with	  clinical	  practice	  guidelines,	  and	  include	  other	  recognized	  medical	  organizations	  when	  appropriate.	  	  The	  American	  Heart	  Association	  (AHA)	  and	  American	  Stroke	  Association	  (ASA)	  work	  together	  in	  producing	  evidenced-­‐based	  information	  regarding	  cerebrovascular	  and	  cardiac	  disease	  and	  are	  recognized	  by	  most	  as	  the	  leaders	  in	  both	  (AHA,	  2010).	  	   The	  AHA	  and	  American	  College	  of	  Cardiology	  Foundation	  (ACCF)	  have	  created	  a	  Task	  Force	  and	  Manual	  to	  oversee	  the	  writing	  committees	  duties	  and	  guideline	  production	  (AHA,	  2010).	  	  The	  Task	  Force	  members	  are	  senior	  experts	  in	  cardiology	  and	  other	  various	  fields	  of	  study	  and	  are	  accustomed	  to	  being	  on	  a	  guideline	  writing	  committee.	  	  The	  specific	  groups	  listed	  in	  this	  guideline	  were	  as	  follows:	  	  the	  American	  Heart	  Association	  Stroke	  Council,	  Council	  on	  Cardiovascular	  and	  Stroke	  Nursing,	  Council	  on	  Clinical	  Cardiology,	  Council	  in	  Epidemiology	  and	  Prevention,	  and	  the	  Council	  for	  High	  Blood	  Pressure	  Research	  (AHA/ASA,	  2014).	  	  These	  councils	  were	  made	  up	  of	  multiple	  disciplines,	  including	  neurology,	  neuroscience	  research,	  internal	  medicine,	  obstetrics/gynecology,	  cardiology,	  pharmacy,	  nursing,	  epidemiology	  and	  public	  policy	  (AHA/ASA,	  2014).	  	  The	  American	  Academy	  of	  Neurology	  and	  the	  American	  Association	  of	  Neurological	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Surgeons	  and	  Congress	  of	  Neurological	  Surgeons	  fully	  endorse	  this	  guideline	  as	  well	  (AHA/ASA,	  2014).	  	  As	  seen	  above,	  all	  relevant	  scopes	  of	  practice	  were	  included	  in	  this	  gathering	  of	  information.	  	  No	  modality	  appears	  to	  be	  left	  out	  upon	  review.	  	  The	  AHA	  created	  this	  guideline	  with	  healthcare	  providers	  to	  be	  the	  target	  audience	  and	  not	  the	  patient.	  	  Patient	  stroke	  awareness	  was	  included	  to	  illustrate	  the	  lack	  of	  stroke	  knowledge	  (awareness	  and	  risk	  factors)	  as	  an	  identifiable	  gap	  to	  the	  provider.	  	  
Rigor	  of	  Development	  	   The	  AHA/ASA	  (2014)	  guideline	  for	  the	  prevention	  of	  stroke	  in	  women	  provides	  clear	  information	  about	  the	  search	  strategy	  including	  databases,	  types	  of	  researched	  utilized,	  and	  grading	  of	  evidence.	  	  The	  aforementioned	  Task	  Force	  nominated	  members	  to	  be	  on	  the	  writing	  committee	  and	  appoint	  a	  chairperson.	  	  A	  support	  staff	  of	  a	  research	  analyst/evidence-­‐based	  medicine	  specialist	  and	  document	  manager	  assisted	  the	  writers	  with	  the	  methodology	  process	  of	  guideline	  development	  (AHA,	  2010).	  	  The	  AHA	  Stroke	  Council’s	  Scientific	  Statement	  Oversight	  Committee	  and	  the	  AHA	  Manuscript	  Oversight	  Committee	  approved	  all	  writing	  committee	  members.	  	   Although	  not	  specified	  in	  the	  methodology	  of	  this	  guideline,	  the	  AHA	  Writing	  Committee	  reviewed	  relevant	  literature	  on	  adults	  only,	  using	  computerized	  searches	  through	  the	  date	  of	  March	  15,	  2013	  (AHA/ASA,	  2014).	  	  A	  specific	  search	  list	  of	  medical	  subject	  headings	  was	  not	  provided.	  	  No	  exclusionary	  criteria	  were	  listed	  upon	  review	  of	  this	  guideline.	  	  “Each	  AHA/ASA	  guideline	  adheres	  to	  levels	  of	  evidence	  and	  classes	  of	  recommendation	  derived	  from	  ACC/AHA	  Guidelines	  Task	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Force.	  	  All	  AHA	  scientific	  statements	  undergo	  blinded	  peer	  review	  and	  are	  reviewed	  and	  approved	  by	  the	  AHA	  Science	  Advisory	  and	  Coordinating	  Committee	  (SACC),	  the	  highest	  scientific	  body	  of	  the	  AHA/ASA	  (AHA,	  2010).”	  	   This	  guideline	  underwent	  extensive	  internal	  AHA	  peer	  review,	  Stroke	  Council	  Leadership	  review,	  and	  review	  of	  the	  Scientific	  Statements	  Oversight	  Committee	  (AHA/ASA,	  2014).	  	  The	  guideline	  addresses	  several	  topics	  related	  to	  stroke	  in	  women	  based	  on	  substantial	  evidence-­‐based	  literature.	  	  The	  key	  recommendations	  are	  explicitly	  linked	  with	  supporting	  evidence.	  	  With	  each	  recommendation	  the	  writers	  include	  the	  statement	  of	  the	  clinical	  objective,	  list	  of	  the	  recommendation(s),	  list	  the	  classification	  and	  level	  of	  the	  supporting	  evidence,	  give	  a	  description	  of	  the	  recommendation	  and	  evidence,	  references,	  and	  include	  an	  evidence	  table	  and/or	  graphs	  for	  illustration.	  	  This	  guideline	  did	  an	  excellent	  job	  in	  providing	  a	  narrative	  and	  visual	  synthesis	  of	  information	  for	  the	  reader.	  	  	  	   Over	  400	  scientific,	  peer-­‐reviewed	  studies	  were	  reviewed	  and	  incorporated	  into	  the	  AHA/ASA	  guideline	  for	  stroke	  prevention	  in	  women.	  	  These	  studies	  included	  multiple	  meta-­‐analysis	  and	  randomized	  clinical	  trials,	  single	  randomized	  trial	  or	  non-­‐randomized	  studies,	  multiple	  prospective	  cohort	  studies,	  expert	  position	  statements,	  and	  case	  studies	  (AHA/ASA,	  2014).	  	  The	  health	  benefits	  and	  harm	  of	  the	  interventions	  were	  covered	  effectively.	  	  However,	  cost-­‐effectiveness	  was	  not	  addressed	  in	  this	  guideline.	  	   The	  ACCF/AHA	  Task	  Force	  is	  continuously	  exploring	  new	  evidence	  and	  processes	  to	  update	  guideline	  content.	  	  The	  Task	  Force	  reviews	  all	  guidelines	  one	  year	  after	  they	  are	  published	  and	  yearly	  thereafter	  for	  possible	  updates.	  	  The	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Research	  Analyst	  and	  the	  Task	  Force	  chair	  monitor	  significant	  new	  clinical	  trials	  and	  peer	  reviewed	  literature	  on	  the	  topic,	  and	  compare	  the	  current	  guideline	  recommendations	  against	  the	  latest	  data.	  	  The	  writing	  committee	  is	  then	  surveyed	  to	  determine	  if	  the	  guideline	  or	  sections	  within	  the	  guideline	  need	  updating.	  	  
Clarity	  and	  Presentation	  	   The	  key	  recommendations	  are	  easily	  identifiable	  to	  the	  reader.	  	  Recommendations	  are	  provided	  for	  stroke	  prevention	  in	  women	  in	  the	  following	  categories:	  prevention	  of	  preeclampsia	  and	  treatment	  of	  hypertension	  in	  pregnancy	  and	  post-­‐partum;	  cerebral	  venous	  thrombosis	  screening	  and	  treatment;	  oral	  contraceptive	  use	  screening	  and	  treatment;	  postmenopausal	  hormone	  therapy	  treatment;	  migraine	  with	  aura	  treatment	  with	  smoking	  cessation;	  obesity/metabolic	  syndrome/lifestyle	  screenings	  and	  interventions;	  atrial	  fibrillation	  screening	  and	  treatment;	  and	  carotid	  stenosis	  screening	  and	  treatment.	  	  The	  AHA/ASA	  (2014)	  guideline	  provides	  the	  examiner	  a	  thorough	  navigation	  through:	  the	  importance	  of	  early	  detection,	  linkage	  with	  cerebrovascular	  complications,	  the	  importance	  of	  risk	  factor	  and	  prevention	  management,	  and	  improving	  a	  woman’s	  risk	  of	  not	  having	  a	  stroke	  (AHA/ASA	  2014).	  	  The	  AHA/ASA	  (2014)	  guideline,	  focused	  on	  risk	  factors	  that	  are	  unique	  to	  and	  more	  common	  in	  women.	  	  These	  topics	  included:	  reproductive	  factors,	  migraine	  with	  aura,	  metabolic	  syndrome,	  and	  atrial	  fibrillation.	  	  Some	  stroke	  risk	  topics	  that	  are	  not	  covered	  in	  detail	  include	  management	  of	  diabetes	  mellitus	  and	  cholesterol,	  because	  there	  are	  no	  female	  specific	  recommendations	  for	  these	  risk	  factors.	  	  This	  guideline	  also	  included	  reviews	  on	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existing	  stroke	  risk	  scoring	  methods,	  which	  demonstrated	  the	  need	  for	  further	  research	  based	  on	  women	  specific	  risk	  factors	  and	  scores.	  	   Each	  category	  is	  supplied	  with	  evidenced-­‐based	  literature,	  evidence	  tables	  and/or	  graphs	  supporting	  their	  recommendations.	  	  The	  guideline	  has	  charts,	  graphs,	  and	  tables	  to	  determine	  and	  monitor	  the	  success	  of	  treatment.	  	  The	  guideline	  incorporates	  different	  management	  options	  for	  distinct	  patient	  population	  types.	  	  Some	  examples	  of	  a	  different	  patient	  population	  management	  would	  be	  treatment	  for	  hypertension	  during	  pregnancy	  or	  the	  association	  with	  different	  postmenopausal	  hormone	  replacement	  therapy	  and	  stroke	  risk	  (AHA/ASA,	  2014).	  	   The	  AHA/ASA	  (2014)	  recommendations	  can	  be	  employed	  in	  all	  clinical	  settings	  pertaining	  to	  women	  to	  aid	  in	  the	  prevention	  and	  therapeutic	  treatments	  to	  prevent	  primary	  stroke.	  	  Each	  categorical	  topic	  has	  a	  Summary	  and	  Gaps	  conclusion	  paragraph	  to	  inform	  the	  reader	  of	  what	  the	  literature	  has	  found	  and	  what	  still	  needs	  to	  be	  discovered.	  	  
Application	  	   The	  AHA/ASA	  (2014)	  guideline	  did	  not	  discuss,	  at	  any	  length,	  potential	  organizational	  barriers.	  	  Only	  knowledge	  gaps	  within	  the	  literature	  to	  inform	  stroke	  risk	  identification	  when	  pertaining	  to	  women	  sub-­‐groups	  were	  discussed.	  	  Also,	  cost	  implications	  to	  the	  provider,	  patient	  or	  nation	  were	  not	  addressed.	  However,	  the	  cost	  to	  the	  provider	  seemed	  as	  if	  they	  would	  be	  minimal.	  	  
Theoretical	  Framework	  	   The	  Health	  Belief	  Model	  (HBM)	  is	  one	  of	  the	  most	  widely	  used	  conceptual	  frameworks	  for	  understanding	  health	  behavior	  in	  context	  of	  health	  education	  and	  
	  	   33	  
health	  promotion.	  	  Social	  Psychologists	  (Hochbaum,	  1958;	  Rosenstock,	  1960,	  1974)	  developed	  this	  model	  in	  the	  mid-­‐twentieth	  century	  to	  explain	  limited	  participation	  of	  individuals	  in	  US	  Public	  Health	  Service	  medical	  screening	  interventions.	  	  This	  model	  has	  been	  revised	  and	  expanded	  by	  incorporating	  individual	  expectations	  and	  perceptions	  (Glanz,	  Rimer,	  &	  Viswanath,	  2008).	  	  	   The	  Health	  Belief	  Model	  (HBM)	  is	  constructed	  around	  an	  individual	  perception	  of	  health	  and	  the	  methodical	  rationales	  upon	  which	  suppositions	  and	  opinions	  are	  formed.	  	  The	  major	  theoretical	  constructs	  of	  the	  HBM	  are	  as	  follows:	  perceived	  susceptibility,	  perceived	  severity,	  perceived	  benefits,	  perceived	  barriers,	  cues	  to	  action,	  and	  self-­‐efficacy	  (Glanz	  et	  al.,	  2008).	  	  The	  HBM	  will	  aid	  disclosure	  of	  what	  is	  considered	  healthy	  or	  non	  healthy	  to	  an	  individual	  or	  group,	  why	  they	  believe	  so,	  and	  how	  they	  plan	  to	  adapt	  their	  lifestyle	  to	  encompass	  or	  reject	  a	  specific	  belief	  (Glanz	  et	  al.,	  2008).	  	  	  The	  HBM	  can	  aid	  the	  practitioner	  and	  the	  individual	  to	  maximize	  participation	  in	  health	  promotion	  against	  stroke,	  evaluate	  behaviors	  as	  to	  why	  an	  individual	  has	  risk	  factors	  for	  stroke	  and	  what	  modifications	  will	  need	  to	  be	  made	  in	  order	  to	  produce	  a	  change	  for	  the	  better.	  	  The	  advanced	  practice	  nurse	  must	  consider	  the	  entwinement	  of	  the	  multiplicity	  of	  intrapersonal	  factors	  such	  as;	  environment,	  socioeconomic	  resources,	  and	  moral	  attributes	  that	  influence	  personal	  perception.	  	  By	  addressing	  each	  and	  investigating	  these	  as	  an	  entity,	  one	  might	  be	  able	  to	  see	  the	  interdependence	  of	  all,	  thusly	  becoming	  better	  prepared	  to	  deal	  with	  the	  complexity	  of	  an	  individual	  seeking	  care.	  	  	   Prevention	  is	  key	  to	  healthy	  outcomes.	  	  As	  a	  primary	  healthcare	  provider,	  the	  advanced	  practice	  nurse	  is	  a	  pivotal	  in	  providing	  pre-­‐emptive	  care	  for	  stroke	  in	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women.	  The	  concepts	  examined	  in	  the	  HBM	  are	  essential	  to	  the	  advance	  practice	  nurse	  in	  pinpointing	  areas	  of	  concern,	  and	  propelling	  care	  and	  interventions	  in	  the	  direction	  needed	  to	  create	  a	  positive	  change.	  	  The	  HBM	  is	  an	  empirically	  tested	  model	  and	  focuses	  on	  prevention	  and	  facilitates	  the	  understanding	  of	  client	  health	  perspectives	  (Glanz	  et	  al.,	  2008).	  	  Susceptibility	  is	  the	  driving	  force	  behind	  the	  model:	  	  the	  higher	  perceived	  susceptibility	  to	  illness,	  the	  more	  likely	  the	  individual	  will	  feel	  exposed	  to	  a	  specific	  health	  problem,	  and	  thus,	  more	  likely	  to	  seek	  expert	  advice.	  	  The	  salient	  features	  of	  this	  model	  are	  to	  identify	  factors	  that	  influence	  attitudes	  towards	  health,	  pursuit	  of	  healthcare,	  and	  consequences	  of	  both.	  	  Health	  promotion	  along	  with	  prevention	  and	  management	  of	  stroke	  is	  a	  feasible	  healthcare	  provider	  goal,	  especially	  when	  guided	  by	  the	  Health	  Belief	  Model	  and	  following	  the	  AHA/ASA	  guideline.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Editorial	  Independence	  	   The	  guideline	  has	  a	  clear	  statement	  that	  the	  work	  done	  was	  completely	  supported	  by	  the	  AHA	  and	  ASA	  (which	  is	  a	  division	  of	  the	  AHA,	  founded	  in	  1997)	  and	  that	  great	  lengths	  are	  taken	  to	  avoid	  any	  actual	  or	  potential	  conflict	  of	  interests.	  The	  guideline	  stated	  that	  the	  American	  Heart	  Association	  makes	  every	  effort	  to	  avoid	  any	  actual	  or	  potential	  conflicts	  of	  interest	  whether	  personal,	  professional,	  or	  business	  interest	  of	  a	  member	  of	  the	  writing	  panel	  (AHA/ASA,	  2014).	  	  All	  members	  of	  the	  writing	  panel	  were	  required	  to	  complete	  and	  submit	  a	  Disclosure	  Questionnaire	  that	  would	  show	  any	  such	  conflict	  of	  interests.	  	  The	  guideline	  also	  included	  a	  table	  derived	  from	  this	  questionnaire,	  and	  listed	  any	  perceived	  conflict	  and	  the	  reason	  as	  to	  why	  (AHA/ASA,	  2014).	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Recommendations	  	   Currently,	  there	  are	  no	  comparable	  guidelines	  specific	  to	  women’s	  stroke	  risk	  and	  prevention	  of	  stroke	  in	  the	  U.S.	  or	  worldwide.	  	  	  After	  searching	  over	  370	  guidelines	  with	  search	  terms	  of	  “stroke”,	  “stroke	  prevention”,	  “primary	  stroke”	  and	  “stroke	  in	  women”	  on	  the	  National	  Guideline	  Clearinghouse	  through	  Agency	  for	  Healthcare	  Research	  and	  Quality;	  only	  one	  guideline,	  among	  U.S.	  literature,	  was	  applicable	  regarding	  primary	  stroke	  prevention.	  	  This	  guideline	  was	  the	  AHA/ASA	  (2011)	  Guidelines	  for	  the	  Primary	  Prevention	  of	  Stroke.	  	  Many	  other	  guidelines	  exist	  regarding	  secondary	  stroke	  prevention,	  acute	  stroke	  care	  and	  intervention,	  and	  individualized	  stroke	  risk	  factor	  recommendations.	  	  	  Since	  this	  guideline	  was	  issued	  from	  the	  same	  national	  organization,	  it	  is	  supported	  from	  the	  same	  research	  and	  implementation	  standards	  as	  the	  AHA/ASA	  2014	  guideline.	  	  To	  date	  these	  are	  the	  only	  primary	  stroke	  prevention	  guidelines	  within	  the	  United	  States.	  	  The	  AHA/ASA	  2014	  guideline	  directs	  the	  reader	  to	  the	  aforementioned	  guideline	  when	  issues	  of	  stroke	  risk	  arise	  pertaining	  to	  both	  men	  and	  women	  equally.	  	  Furthermore,	  both	  AHA/ASA	  primary	  stroke	  prevention	  guidelines	  should	  be	  taken	  into	  consideration	  among	  healthcare	  providers	  for	  all	  persons	  across	  the	  continuum	  of	  care.	  	  	  	  The	  AHA/ASA	  (2014)	  guidelines	  overall	  did	  an	  outstanding	  job	  in	  providing	  evidence	  and	  recommendations	  on	  many	  key	  topics	  relating	  to	  prevention	  of	  stroke	  in	  women,	  including	  charts	  and	  graphs	  focused	  on	  female	  specific	  stroke	  risk	  factors	  and	  treatment	  options.	  	  	   The	  AHA/ASA	  (2014)	  Stroke	  Prevention	  in	  Women	  is	  a	  highly	  reputable	  and	  sound	  guideline	  and	  supports	  its	  recommendations	  with	  the	  most	  esteemed	  and	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current	  scientific	  evidence	  available.	  	  This	  guideline	  comes	  highly	  recommend	  for	  all	  primary	  care	  providers,	  including	  nurse	  practitioners.	  	  The	  authors	  of	  this	  guideline	  state	  that	  their	  goal	  was	  three-­‐fold:	  to	  review	  risk	  factors	  that	  are	  either	  unique	  to	  women	  or	  affects	  women’s	  risk	  of	  stroke	  differently;	  to	  determine	  if	  there	  is	  a	  need	  for	  a	  female-­‐specific	  stroke	  risk	  score;	  and	  to	  empower	  women	  and	  their	  families	  by	  understanding	  their	  personal	  risk	  factors	  and	  how	  they	  can	  reduce	  their	  chance	  of	  stroke.	  
Summary	  All	  adult	  individuals	  should	  be	  knowledgeable	  of	  stroke	  and	  stroke	  risk	  factors,	  especially	  women.	  	  In	  conjunction	  with	  providing	  important	  personal	  health	  promotion,	  the	  advanced	  practice	  nurse	  should	  seek	  to	  identify	  specific	  risk	  factors,	  educate	  their	  patients	  in	  ways	  to	  reduce	  these	  risks,	  and	  advise	  therapeutic	  interventions	  as	  warranted	  based	  on	  the	  AHA/ASA	  guidelines.	  	  An	  aggressive	  approach	  to	  screening,	  establishing	  the	  presence	  of	  specific	  stroke	  risk	  factors,	  and	  intervening	  will	  reduce	  the	  prevalence	  of	  first	  stroke.	  	  In	  turn,	  reducing	  its	  calamitous	  consequences	  that	  plague	  our	  society	  and	  contribute	  to	  the	  rising	  costs	  of	  healthcare.	  	   	   	  	   The	  importance	  of	  modeling	  and	  introducing	  a	  clinical	  practice	  guideline	  aimed	  at	  reduction	  of	  first	  stroke	  in	  women	  cannot	  be	  over	  estimated.	  	  The	  importance	  lies	  in	  the	  potential	  to	  individually	  and	  publically	  integrate,	  in	  an	  efficient	  and	  effective	  manner,	  the	  evidenced	  based	  clinical	  guidelines	  established	  by	  the	  AHA/ASA,	  and	  to	  promote	  awareness	  of	  the	  ability	  to	  reduce	  primary	  stroke	  incidence	  while	  better	  managing	  control	  over	  modifiable	  stroke	  risk	  factors.	  
	  	   37	  
	   	   References	  American	  Heart	  Association.	  (2010,	  June).	  	  Methodology	  Manual	  and	  Policies	  From	  
	   the	  ACCF/AHA	  Task	  Force	  on	  Practice	  Guidelines.	  Retrieved	  from:	  http://my.americanheart.org/idc/groups/ahamahpublic/@wcm/@sop/documents/downloadable/ucm_319826.pdf	  American	  Stroke	  Association.	  (2012,	  May	  1).	  Impact	  of	  Stroke.	  Retrieved	  from:	  http://www.strokeassociation.org/STROKEORG/AboutStroke/Impact-­‐of-­‐Stroke_UCM_310728_Article.jsp	  American	  Heart	  Association.	  (2013).	  	  Heart	  Disease	  and	  Stroke	  Statistics.	  Retrieved	  from:	  http://www.heart.org/idc/groups/heart-­‐public/@wcm/@adv/documents/downloadable/ucm_307175.pdf	  AHA/ASA.	  (2014).	  	  Bushnell	  C,	  McCullough	  LD,	  Awad	  IA,	  Chireau	  MV,	  Fedder	  WN,	  Furie	  KL,	  Howard	  VJ,	  Lichtman	  JH,	  Lisabeth	  LD,	  Piña	  IL,	  Reeves	  MJ,	  Rexrode	  KM,	  Saposnik	  G,	  Singh	  V,	  Towfighi	  A,	  Vaccarino	  V,	  Walters	  MR;	  on	  behalf	  of	  the	  American	  Heart	  Association	  Stroke	  Council,	  Council	  on	  Cardiovascular	  and	  Stroke	  Nursing,	  Council	  on	  Clinical	  Cardiology,	  Council	  on	  Epidemiology	  and	  Prevention,	  and	  Council	  for	  High	  Blood	  Pressure	  Research.	  Guidelines	  for	  the	  prevention	  of	  stroke	  in	  women:	  a	  statement	  for	  healthcare	  professionals	  from	  the	  American	  Heart	  Association/American	  Stroke	  Association.	  Stroke.	  2014;45,1-­‐44.	  CDC/	  National	  Center	  for	  Health	  Statistics.	  (2013,	  December,	  30).	  Leading	  Causes	  of	  
Death.	  Retrieved	  from:	  http://www.cdc.gov/nchs/fastats/lcod.htm	  	  
	  	   38	  
CDC	  Office	  of	  Women’s	  Health.(2013,	  October).	  Leading	  Cause	  of	  Female	  Deaths.	  Retrieved	  from:	  http://www.cdc.gov/women/lcod/2010/index.htm	  Glanz,	  K.,	  Rimer,	  B.,	  &Viswanath,	  K.	  (2008).	  The	  Health	  Belief	  Model.	  In	  K.	  Glanz,	  B.	  Rimer,	  &	  K.	  Viswanath	  (Eds.),	  Health	  Behavior	  and	  Health	  Education	  Theory,	  
Research,	  and	  Practice	  (pp.45-­‐62).	  SanFransico,	  CA:	  Jossey-­‐Bass.	  Kentucky	  Cabinet	  for	  Health	  and	  Family	  Services	  (KCHFS).	  (2014,	  January).	  
Kentucky	  Stroke	  Fact	  Sheet.	  Retrieved	  from:	  http://chfs.ky.gov/dph/info/dpqi/cd/heart+disease+and+stroke+prevention.htm	  Liao,	  J.,	  Greenlund,	  K.,	  J.,	  Croft,	  J.,	  B.,	  Keenan,	  N.,	  L.,	  &	  Giles,	  W.,	  H.,	  (	  2009).	  Factors	  	   	  	   Explaining	  Excess	  Stroke	  Prevalence	  in	  the	  US	  Stroke	  Belt.	  Stroke;40;3336-­‐	   3341	  National	  Institute	  of	  Neurological	  Disorders	  and	  Stroke	  (NINDS),	  National	  Institute	  of	  Health.	  (2013).	  Brain	  basics:	  preventing	  Stroke	  (NIH	  Publication	  No.	  04-­‐3440b).	  Retrieved	  from	  http://www.ninds.nih.gov/disorders/stroke/preventing_stroke.htm.	  National	  Stroke	  Association	  (NSA).	  (2010).	  Women	  and	  Stroke.	  Retrieved	  from:	  http://www.stroke.org/site/PageServer?pagename=women	  The	  AGREE	  Collaboration.	  (2001).	  Appraisal	  of	  Guidelines	  for	  Research	  and	  	  	  	   Evaluation	  (AGREE)	  Instrument.	  Retrieved	  from	  www.agreecollaboration.org	  	  World	  Health	  Organization.	  (2004,	  September	  24).	  Health	  Topics:	  Stroke,	  
Cerebrovascular	  Accident.	  Retrieved	  from:	  
http://www.who.int/topics/cerebrovascular_accident/en/	  
	  	   39	  






















	  	   40	  
Appendix	  A	  
	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  http://www.cdc.gov/dhdsp/state_program/images/ky_graph.gif,	  (2005)	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	   	  	  	  	  	  	  	  	  
	  	   41	  
	  	  	  	   	  	  	  	  Primary	  Stroke	  Prevention:	  3-­‐hydroxy-­‐3-­‐methyl-­‐glutaryl-­‐coenzyme	  A	  (HMG-­‐CoA)	  Reductase	  Inhibitor	  (statin)	  Use	  in	  the	  Diabetic	  Patient	  Amy	  L.	  Hatcher,	  DNP,	  RN	  University	  of	  Kentucky	  College	  of	  Nursing	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  	   42	  
Abstract	  
Purpose:	  	  The	  primary	  objective	  for	  this	  retrospective	  chart	  review	  was	  to	  evaluate	  provider	  adherence	  to	  the	  2011	  AHA/ASA	  Primary	  Stroke	  Prevention	  guideline	  of	  prescribing	  a	  statin	  to	  all	  diabetic	  patients	  for	  primary	  prevention	  of	  stroke,	  regardless	  of	  dyslipidemia.	  	  A	  second	  aim	  of	  this	  study	  is	  to	  identify	  provider	  facilitators	  and	  barriers	  to	  prescribing	  a	  statin	  therapy	  for	  primary	  prevention.	  	  
Methods:	  	  Using	  a	  retrospective	  study	  design,	  a	  random	  sample	  of	  100	  medical	  records	  of	  diabetic	  patients	  presenting	  to	  a	  university	  women’s	  health	  clinic	  within	  the	  previous	  year	  were	  reviewed	  for	  statin	  use	  and	  rationale.	  	  	  
Results:	  	  Of	  the	  100	  diabetic	  patients	  sampled,	  only	  69%	  were	  currently	  prescribed	  a	  statin	  therapy.	  	  Furthermore,	  only	  one	  patient	  had	  a	  diabetic	  rationale	  for	  statin	  use.	  	  Primary	  stroke	  prevention	  counseling	  and	  therapy	  aimed	  at	  prevention	  of	  primary	  stroke	  will	  be	  completed	  at	  a	  future	  date.	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Introduction	  
	  Stroke	  incidence	  in	  women	  and	  the	  specific	  impact	  of	  diabetes	  risk	  and	  primary	  prevention	  strategies	  has	  yet	  to	  be	  investigated.	  	  Stroke	  prevention	  in	  women	  with	  diabetes	  is	  a	  serious	  undertaking	  as	  stroke	  was	  found	  to	  be	  more	  prevalent	  and	  more	  fatal	  in	  the	  female	  population	  (American	  Heart	  Association/American	  Stroke	  Association	  [AHA/ASA],	  2014).	  	  Heart	  disease	  and	  stroke	  are	  the	  number	  one	  causes	  of	  death	  and	  disability	  among	  people	  with	  type	  2	  diabetes	  (AHA,	  2013).	  	  Diabetics	  are	  2	  to	  4	  times	  more	  likely	  to	  have	  heart	  disease	  or	  stroke	  than	  adults	  without	  diabetes	  (AHA,	  2013).	  	  	  Stroke	  is	  currently	  one	  of	  the	  leading	  causes	  of	  death	  worldwide.	  	  Ongoing	  research	  has	  focused	  on	  ways	  to	  reduce	  the	  incidence	  and	  mortality	  rates	  associated	  with	  stroke	  in	  the	  diabetic	  population.	  	  The	  purpose	  of	  this	  paper	  is	  to	  describe	  the	  results	  of	  a	  retrospective	  chart	  review	  at	  a	  women’s	  primary	  care	  university	  health	  clinic	  in	  the	  southeastern	  United	  States.	  	  The	  review	  will	  examine	  provider	  guideline	  adherence	  for	  primary	  stroke	  prevention	  in	  diabetic	  women	  through	  the	  use	  of	  prescribing	  a	  HMG-­‐CoA	  Reductase	  Inhibitor	  (statin).	  
Scope	  and	  Practice	  
Cerebrovascular	  Disease	  Cerebrovascular	  infarct	  or	  hemorrhage	  (stroke)	  is	  the	  fourth	  leading	  cause	  of	  death	  and	  one	  of	  the	  most	  common	  causes	  of	  adult	  disability	  in	  the	  United	  States.	  It	  is	  currently	  the	  second	  leading	  cause	  of	  death	  worldwide	  (Centers	  for	  Disease	  Control	  [CDC],	  2013;	  National	  Institute	  of	  Neurological	  Disorders	  and	  Stroke	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[NINDS],	  2013;	  World	  Health	  Organization	  [WHO],	  2013).	  	  By	  2020,	  stroke	  will	  become	  the	  leading	  cause	  of	  death	  and	  disability	  worldwide	  (WHO,	  2004).	  	  	  	   Stroke	  results	  from	  a	  disruption	  of	  the	  blood	  supply	  to	  the	  brain.	  	  Loss	  of	  blood	  supply	  secondary	  to	  a	  circulatory	  vessel	  occlusion	  results	  in	  a	  cascade	  of	  events,	  ultimately	  leading	  to	  loss	  of	  brain	  tissue	  and	  function.	  Persons	  sustaining	  a	  stroke	  may	  experience	  loss	  of	  movement	  and/or	  ability	  to	  perceive	  sensation,	  inability	  to	  speak	  or	  understand,	  and/or	  loss	  of	  vision.	  	  On	  average	  795,000	  new	  cases	  of	  strokes	  or	  recurrent	  strokes	  occur	  annually	  within	  the	  United	  States,	  with	  approximately	  160,000	  of	  these	  resulting	  in	  death	  (ASA,	  2012;	  NINDS,	  2013).	  	  	   It	  has	  been	  estimated	  that	  up	  to	  80%	  of	  strokes	  are	  preventable	  by	  controlling	  risk	  factors	  (NINDS,	  2013).	  	  The	  risks	  of	  suffering	  a	  stroke	  may	  be	  either	  modifiable	  or	  non-­‐modifiable.	  	  Some	  of	  the	  major	  modifiable	  risk	  factors	  include	  hypertension,	  tobacco	  abuse,	  dyslipidemia,	  and	  glucose	  intolerance.	  	  Non-­‐modifiable	  risk	  factors	  for	  stroke	  are	  age,	  genetics,	  race,	  and	  gender	  (ASA,	  2012).	  	  	  
Women	  and	  Cerebrovascular	  Disease	  	   Female	  gender	  is	  a	  non-­‐modifiable	  stroke	  risk	  factor.	  	  Stroke	  is	  the	  third	  leading	  killer	  of	  all	  women	  in	  the	  United	  States,	  and	  the	  fourth	  leading	  cause	  in	  men	  (AHA/ASA,	  2014;	  CDC,	  2013).	  	  Women	  suffer	  from	  55,000	  more	  strokes	  annually,	  and	  die	  from	  strokes	  more	  often	  than	  men	  each	  year	  (AHA/ASA,	  2014).	  	  Some	  of	  the	  stroke	  risk	  factors	  that	  are	  exclusive	  to	  women	  or	  affect	  women	  more	  often	  than	  men	  are	  as	  follows:	  pregnancy	  and	  preeclampsia,	  oral	  contraceptive	  use,	  hormone	  replacement	  therapy,	  migraines	  with	  auras,	  metabolic	  syndrome,	  and	  atrial	  fibrillation	  (AHA/ASA,	  2014).	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Cerebrovascular	  Disease	  in	  Kentucky	   	  	   In	  2009,	  strokes	  accounted	  for	  5%	  (5th	  leading	  cause)	  of	  all	  deaths	  in	  Kentucky,	  and	  the	  state	  was	  ranked	  11th	  nationally	  for	  stroke	  mortality	  rates	  (AHA,	  2013;	  Kentucky	  Cabinet	  of	  Health	  and	  Family	  Services	  [KCHFS],	  2014).	  	  Residents	  of	  Kentucky	  are	  highly	  susceptible	  to	  stroke	  by	  living	  within	  the	  “stroke	  belt”,	  which	  places	  them	  at	  higher	  risk	  for	  contributing	  stroke	  risk	  factors	  (Liao,	  Greenlund,	  Croft,	  Keenan	  &	  Giles,	  2009).	  	  The	  stroke	  belt	  consists	  of	  the	  following	  states:	  	  Alabama,	  Arkansas,	  Georgia,	  Indiana,	  Kentucky,	  Louisiana,	  Mississippi,	  North	  Carolina,	  South	  Carolina,	  Tennessee,	  and	  Virginia	  (Liao	  et	  al.,	  2009).	  	  When	  states	  within	  the	  stroke	  belt	  were	  compared	  to	  states	  outside	  of	  the	  stroke	  belt	  factors	  such	  as	  socioeconomic	  status,	  race/ethnicity,	  and	  education	  of	  the	  representative	  populations	  were	  found	  to	  correlate	  with	  stoke	  prevalence.	  	  	  These	  cultural	  indicators	  often	  lead	  to	  an	  increased	  prevalence	  of	  other	  stroke	  specific	  risk	  factors	  such	  as	  obesity,	  smoking,	  hypertension,	  diabetes,	  and	  coronary	  heart	  disease	  (Liao	  et	  al.,	  2009).	  	   In	  addition	  to	  the	  predominately	  devastating	  consequences	  of	  stroke	  are	  the	  financial	  implications	  to	  consider.	  	  In	  2010,	  the	  annual	  costs	  of	  ischemic	  cerebrovascular	  disease	  and	  the	  related	  cost	  of	  disability	  and	  loss	  of	  production	  in	  the	  United	  States	  exceeded	  $73.7	  billion	  (ASA,	  2012).	  	  	  As	  the	  population	  ages	  so	  does	  the	  economic	  impact	  of	  presiding	  health	  disparities,	  especially	  stroke.	  	  In	  2010,	  stroke-­‐related	  hospitalizations	  cost	  the	  state	  of	  Kentucky	  over	  $329	  million	  (KCHFS,	  2014).	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Diabetes	   	  	   Diabetes	  affects	  25.8	  million	  people	  in	  the	  United	  States,	  8.3%	  of	  the	  population,	  and	  an	  estimated	  7	  million	  people	  are	  undiagnosed	  (CDC,	  2011).	  	  Diabetes	  is	  the	  leading	  cause	  of	  kidney	  failure,	  non-­‐traumatic	  lower	  limb	  amputations,	  and	  blindness	  among	  adults	  in	  the	  United	  States	  (CDC,	  2011).	  	  Diabetes	  is	  a	  major	  cause	  of	  stroke	  and	  heart	  disease,	  and	  the	  seventh	  leading	  cause	  of	  death	  in	  the	  U.S.	  (CDC,	  2011).	  	  Diabetes	  also	  exhibits	  a	  disproportionate	  strain	  on	  racial	  and	  ethnic	  minorities	  (reportedly	  Hispanics	  (11.8%),	  African	  Americans	  (12.6%),	  and	  American	  Indians	  (33%)	  when	  compared	  to	  Caucasians	  (7.1%);	  with	  higher	  prevalence	  rates,	  more	  complications	  and	  worse	  diabetic	  control	  (Peek,	  Cargill	  &	  Huang,	  2007;	  CDC,	  2011).	  	  Minority	  groups	  were	  also	  found	  to	  have	  lower	  quality	  of	  care	  (outcomes)	  (Peek	  et	  al.,	  2007).	  	  	  	   Total	  cost	  (indirect	  and	  direct)	  in	  2012	  is	  equal	  to	  254	  billion	  dollars	  annually,	  a	  41%	  increase	  from	  the	  cost	  5	  years	  before	  in	  2007	  (American	  Diabetes	  Association,	  2013).	  	  	  
Diabetes	  and	  Stroke	  	   One-­‐third	  of	  all	  acute	  stroke	  patients	  have	  diabetes	  mellitus	  (Karsito,	  2008).	  	  Diabetics	  are	  at	  an	  increased	  risk	  for	  stroke	  due	  to	  several	  factors.	  	  Diabetics	  have	  a	  decreased	  endothelium-­‐dependent	  vasodilatation	  due	  to	  decreased	  or	  impaired	  nitric	  oxide	  (NO)	  production,	  which	  causes	  atherosclerotic	  plaques	  to	  be	  destabilized	  (Air	  &	  Kissela,	  2007).	  	  Diabetics	  also	  are	  in	  a	  chronic	  inflammatory	  state,	  which	  leads	  to	  hypercoaguability	  and	  hyperaggregation,	  and	  have	  been	  found	  to	  have	  an	  increase	  carotid	  intima-­‐media	  thickness	  (CIMT)	  (Air	  &	  Kissela,	  2007).	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Carotid	  bruit	  screening	  should	  be	  considered	  in	  all	  diabetic	  patients.	  	  Incidental	  findings	  of	  carotid	  bruits	  in	  asymptomatic	  diabetic	  patients	  have	  been	  found	  to	  have	  a	  greater	  than	  6	  times	  the	  risk	  of	  first	  stroke	  in	  the	  first	  2	  years	  of	  finding,	  than	  those	  without	  a	  bruit	  (Karsito,	  2008).	  	  Additional	  future	  risk	  factors	  for	  stroke	  in	  diabetics	  are	  QTc	  interval	  prolongation,	  and	  proteinuria	  (3.23	  times	  increase	  risk	  for	  stroke)	  (Karsito,	  2008).	  	  Karsito	  (2008)	  also	  found	  that	  the	  peak	  age	  of	  stroke	  for	  black	  diabetic	  Americans	  was	  34-­‐45	  years	  of	  age,	  and	  45-­‐64	  years	  of	  age	  in	  white	  diabetic	  Americans.	  
Statin	  Use	  in	  Diabetics	  	   Statins	  have	  been	  contributors	  in	  reducing	  stroke	  since	  their	  arrival	  to	  the	  medical	  world,	  by	  reducing	  and	  stabilizing	  plaques	  within	  the	  arteries.	  	  Diabetics	  are	  at	  higher	  risk	  for	  developing	  dyslipidemia	  due	  to	  glucose	  attaching	  to	  LDL,	  causing	  glycated	  lipoproteins	  to	  stay	  in	  the	  blood	  stream	  longer	  and	  wreak	  havoc	  within	  the	  blood	  vessels,	  leading	  to	  atherosclerosis	  (Bucala,	  1997;	  Lopes-­‐Virella,	  Klein,	  Lyons,	  Stevenson	  &	  Witztum,	  1988).	  	  Statins	  help	  up-­‐regulate	  NO	  synthesis	  and	  stabilize	  atherosclerotic	  plaques	  (Air	  &	  Kissela,	  2007).	  Statins	  exert	  protective	  effects	  against	  stroke	  independent	  of	  changes	  in	  cholesterol	  levels	  (Air	  &	  Kissela,	  2007;	  AHA/ASA,	  2011).	  	  Statin	  treatment	  can	  now	  be	  recommended	  for	  stroke	  prevention	  even	  in	  patients	  who	  do	  not	  have	  cardiovascular	  disease,	  regardless	  of	  diabetes	  status	  (Air	  &	  Kissela,	  2007).	  	  However,	  diabetic	  patients	  benefit	  greatly	  from	  statin	  treatment	  and	  should	  consider	  statin	  use	  for	  their	  stroke	  prevention	  regimen	  	  (Air	  &	  Kissela,	  2007).	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   Several	  studies	  have	  shown	  the	  protective	  benefit	  of	  statin	  therapy	  against	  stroke,	  in	  patients	  without	  cardiovascular	  disease	  and/or	  dyslipidemia.	  	  This	  benefit	  is	  even	  more	  magnified	  in	  the	  diabetic	  population	  due	  to	  its	  lipid-­‐lowering	  and	  anti-­‐inflammatory	  roles	  (Lakhan,	  Bagchi,	  &	  Hofer,	  2010).	  	   Treatment	  with	  a	  statin	  showed	  a	  significant	  25%	  risk	  reduction	  in	  the	  first-­‐time	  occurrence	  of	  major	  cardiovascular	  and	  cerebrovascular	  events	  in	  diabetic	  patients	  with	  and	  without	  vascular	  disease	  (De	  Vries,	  Denig,	  Pouwels,	  Postma	  and	  Hak,	  2012;	  Kearney,	  et	  al.	  2008).	  	  Beneficial	  effects	  of	  primary	  statin	  therapy	  in	  acute	  ischemic	  stroke	  were	  also	  shown	  in:	  whites,	  diabetics,	  elderly	  patients	  with	  hypertension	  and	  other	  vascular	  diseases,	  and	  patients	  with	  ideal	  low-­‐density	  lipoprotein	  (LDL)	  levels	  (Lakhan	  et	  al.,	  2010).	  	  	  
Specific	  Satin	  Use	  in	  Stroke	  Prevention	  	   In	  the	  Heart	  Protection	  Study	  (2002),	  simvastatin	  produced	  a	  substantial	  24%	  reduction	  of	  first	  cardiovascular	  and/or	  cerebrovascular	  events,	  irrespective	  of	  their	  initial	  cholesterol	  concentrations.	  	  	  Pravastatin	  reduced	  stroke	  occurrence	  by	  12%	  and	  all	  other	  statins	  by	  24%	  (Cheung,	  Lauder,	  Lau	  &	  Kuman,	  2004).	  	  	  The	  use	  of	  atorvastatin	  10	  mg	  daily	  in	  type	  2	  diabetic	  patients	  with	  no	  history	  of	  cardiovascular	  disease	  and	  without	  high	  LDL	  cholesterol	  concentrations	  demonstrated	  a	  substantial	  reduction	  in	  reduction	  of	  stroke	  (48%);	  major	  cardiovascular	  events	  (37%);	  and	  (27%)	  in	  all-­‐cause	  mortality	  (Colhoun	  et	  al.,	  2004).	  	  
Clinical	  Practice	  Guidelines	  	   In	  2011	  the	  AHA/ASA	  developed,	  Guidelines	  for	  the	  Primary	  Prevention	  of	  Stroke:	  A	  Guideline	  for	  Healthcare	  Professionals.	  	  This	  guideline	  was	  originally	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published	  as:	  A	  Statement	  for	  Healthcare	  Providers	  on	  Primary	  Prevention	  of	  Ischemic	  Stroke	  in	  2001.	  	  It	  was	  revised	  and	  became	  a	  guideline	  in	  2006	  and	  revised	  and	  republished	  again	  in	  2011.	  	  “This	  guideline	  provides	  an	  overview	  of	  the	  evidence	  on	  established	  and	  emerging	  risk	  factors	  for	  stroke	  to	  provide	  evidence-­‐based	  recommendations	  for	  the	  reduction	  of	  risk	  of	  a	  first	  stroke	  (AHA/ASA,	  2011,	  p.517).”	  	   The	  recommendations	  from	  this	  guideline	  are	  as	  follows:	  	   	   Recommendation:	  (Class	  I;	  Level	  of	  Evidence	  A)	  	   	   1.	  Treatment	  of	  adults	  with	  diabetes	  with	  a	  statin,	  especially	  those	  	  	   	   with	  additional	  risk	  factors,	  is	  recommended	  to	  lower	  risk	  of	  a	  first	  	  	   	   stroke	  	  	   	   2.	  Treatment	  with	  an	  HMG-­‐CoA	  reductase	  inhibitor	  (statin)	  	   	  	   	   medication	  in	  addition	  to	  therapeutic	  lifestyle	  changes	  with	  LDL-­‐	  	   	   cholesterol	  goals	  as	  reflected	  in	  the	  NCEP	  guidelines	  is	  recommended	  	  	   	   for	  primary	  prevention	  of	  ischemic	  stroke	  in	  patients	  with	  coronary	  	  	   	   heart	  disease	  or	  certain	  high-­‐risk	  conditions	  such	  as	  diabetes	  	   	   (AHA/ASA,	  2011,	  p.	  532,	  535)	  
	  	   The	  AHA/ASA	  (2011)	  guideline	  discussed	  the	  benefits	  of	  high-­‐intensity	  statin	  therapy	  in	  diabetics	  on	  ischemic	  stroke	  by	  causing	  a	  reduction	  of	  progression	  or	  induced	  regression	  of	  atherosclerosis	  and	  a	  reduction	  carotid	  intima	  media	  thickness	  (IMT).	  	  Also,	  patients	  who	  were	  treated	  with	  a	  statin	  and	  had	  type	  2	  diabetes	  (with	  at	  least	  1	  additional	  risk	  factor;	  retinopathy,	  albuminuria,	  current	  smoking,	  or	  hypertension;	  and	  a	  (LDL)	  of	  <160	  mg/dL	  without	  a	  prior	  history	  of	  CVD	  resulted	  in	  a	  48%	  reduction	  in	  stroke	  (AHA/ASA,	  2011).	  	  	   Similarly,	  the	  Adult	  Treatment	  Panel	  IV	  (ATP	  IV)	  guidelines	  have	  recommended	  that	  all	  patients	  with	  diabetes	  (age	  40-­‐75	  years)	  with	  LDL70-­‐189	  mg/dl	  and	  without	  any	  evidence	  of	  CVD	  should	  receive	  moderate	  dose	  statin	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therapy	  as	  follows:	  atorvastatin	  10-­‐20mg,	  rosuvastatin	  5-­‐10	  mg,	  pravastatin	  40-­‐80	  mg,	  simvastatin	  20-­‐40	  mg;	  and	  to	  consider	  high	  dose	  statin	  if	  10-­‐yr	  risk	  is	  >7.5	  %	  (Stone	  et	  al.,	  2013).	  The	  evolution	  and	  consequences	  of	  these	  findings	  warrant	  evaluation	  to	  provide	  practitioners	  with	  a	  guideline	  to	  aid	  prevention	  of	  first	  stroke	  in	  diabetic	  women.	  	  In	  conglomeration	  with	  early	  recognition,	  the	  potential	  for	  stroke	  may	  be	  deferred	  through	  intervention	  of	  such	  a	  high-­‐risk	  modifiable	  factor	  as	  diabetes.	  	  
Retrospective	  Chart	  Review	  
Objectives	  
	   The	  primary	  objective	  for	  the	  retrospective	  chart	  review	  was	  to	  evaluate	  provider	  adherence	  to	  prescribing	  a	  statin	  to	  all	  diabetic	  patients	  for	  primary	  prevention	  of	  stroke,	  regardless	  of	  dyslipidemia.	  	  	  
Methods	  
	   Study	  Designs	  and	  Data	  Extraction.	  	  
	   The	  design	  of	  this	  study	  was	  a	  descriptive	  retrospective	  chart	  review.	  	  Approval	  for	  the	  completion	  of	  this	  study	  was	  obtained	  from	  the	  university	  Institutional	  Review	  Board	  (IRB)	  prior	  to	  data	  collection.	  	  A	  data	  extraction	  Excel	  spreadsheet	  was	  created	  used	  to	  collect	  data.	  	  The	  data	  were	  de-­‐identified	  prior	  to	  being	  recorded	  on	  the	  data	  extraction	  form.	  	  A	  list	  of	  244	  medical	  record	  numbers	  was	  obtained	  and	  a	  randomly	  selected	  sample	  of	  100	  electronic	  patient	  medical	  records	  from	  July	  1,	  2012	  to	  July	  31,	  2013	  was	  selected.	  	  The	  sample	  n=100,	  was	  selected	  using	  a	  populated	  random	  number	  software	  (RANDOM,	  2014).	  	  This	  software	  states	  that	  it	  is	  a	  true	  random	  number	  service	  that	  generates	  randomness	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via	  atmospheric	  noise.	  	  	  Medical	  records	  were	  reviewed	  for	  49	  different	  items;	  see	  (Appendix	  A)	  for	  list	  of	  patient	  information	  collected.	  	  All	  the	  de-­‐identified	  data	  collected	  during	  the	  review	  were	  stored	  on	  the	  principal	  investigator’s	  personal	  password	  protected	  laptop.	  	  	  
	   Inclusion	  and	  Exclusion	  Criteria.	  	   A	  primary	  women’s	  health	  clinic	  was	  the	  location	  for	  this	  study.	  	  	  Inclusion	  criteria	  consisted	  of:	  any	  patient	  seen	  in	  the	  Women’s	  Clinic	  with	  Diabetes	  Type	  1	  or	  Diabetes	  Type	  2	  (ICD-­‐9	  Codes,	  230.00-­‐250-­‐93),	  18	  years	  of	  age	  or	  older,	  and	  seen	  by	  any	  provider	  between	  the	  dates	  of	  July	  1,	  2012	  to	  July	  31,	  2013.	  	  Since	  the	  focus	  of	  this	  study	  is	  primary	  prevention;	  exclusion	  criteria	  included	  any	  patient	  who	  had	  a	  previous	  history	  of	  a	  cerebrovascular	  accident	  (CVA).	  	  	  
	   Study	  Population.	  	   This	  study	  was	  completed	  in	  a	  women’s	  primary	  care	  practice	  located	  in	  an	  urban,	  university	  setting.	  	  The	  practice	  consists	  of	  physicians	  and	  nurse	  practitioners	  that	  provide	  primary	  care	  for	  women	  ranging	  in	  age	  from	  18	  years	  and	  up.	  	  
Data	  Analysis	  	   Results	  from	  the	  retrospective	  medical	  record	  review	  were	  analyzed	  using	  Statistical	  Analysis	  System	  (SAS)	  9.3	  software.	  	  Descriptive	  statistics	  were	  used	  to	  assess	  age,	  race,	  insurance	  type,	  stroke	  risk	  factors,	  active	  diagnoses	  related	  to	  stroke	  risk	  factors,	  prescribed	  statin,	  and	  rationale	  for	  or	  against	  statin	  use.	  	  Medication	  related	  to	  diabetes,	  hypertension,	  dyslipidemia,	  anticoagulation,	  and	  depression,	  as	  well	  as	  the	  associated	  ICD-­‐9	  codes,	  were	  also	  recorded.	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Results	  	   Of	  the	  100	  medical	  records	  reviewed,	  the	  mean	  patient	  age	  was	  57.5,	  the	  median	  age	  59,	  with	  patients	  ranging	  in	  age	  from	  27-­‐91	  years	  old.	  	  Seventy-­‐five	  percent	  were	  Caucasian	  and	  the	  remaining	  25%	  were	  African	  American.	  	  Out	  of	  the	  100	  diabetic	  patients,	  69	  were	  on	  a	  statin	  therapy	  and	  96%	  of	  those	  on	  a	  statin	  had	  a	  dyslipidemia	  diagnosis	  for	  the	  rationale;	  3%	  coronary	  artery	  disease	  (CAD);	  and	  1%	  diabetes.	  	  In	  reviewing	  rationales	  against	  statin	  therapy,	  7%	  of	  the	  31	  patients	  not	  on	  a	  statin	  listed	  “statin-­‐intolerance”	  as	  their	  reasoning	  and	  the	  remaining	  had	  no	  rationale	  listed	  for	  not	  prescribing	  a	  statin.	  	  Several	  specific-­‐stroke	  risk	  factors	  of	  this	  population	  were	  also	  reviewed:	  BMI	  >25	  (98%),	  tobacco	  use	  (14%),	  alcohol	  use	  (45%),	  hypertension	  (82%),	  dyslipidemia	  (82%),	  coronary	  artery	  disease	  (CAD)	  (12%),	  atherosclerosis	  (14%),	  migraine	  with	  aura	  (2%),	  hormone	  replacement	  therapy	  (HRT)	  (11%),	  and	  atrial-­‐fibrillation	  (3%).	  	  Diabetics	  were	  found	  to	  have	  a	  high	  percentage	  (82%)	  of	  co-­‐existing	  conditions	  of	  hypertension	  and	  dyslipidemia.	  	  
Discussion	   	  	   An	  assumption	  for	  primary	  prevention	  in	  a	  diabetic	  could	  not	  be	  made,	  but	  it	  is	  still	  uncertain.	  	  The	  data	  clearly	  shows	  that	  most	  diabetic	  patients	  have	  a	  co-­‐existing	  diagnosis	  of	  dyslipidemia.	  	  This	  makes	  it	  difficult	  to	  ascertain	  if	  statin	  therapy	  is	  being	  used	  only	  for	  the	  dyslipidemia	  diagnoses	  or	  in	  addition	  as	  a	  primary	  prevention	  strategy.	  	  Lab	  values	  were	  not	  evaluated	  in	  this	  study	  to	  see	  if	  dyslipidemic	  patients	  that	  were	  not	  on	  a	  statin	  were	  within	  normal	  limits	  through	  other	  measures	  such	  as	  diet	  and	  exercise.	  	  	  Only	  2	  out	  of	  6	  patients	  that	  were	  on	  a	  medication	  for	  dyslipidemia,	  other	  than	  a	  statin	  (e.g.,	  fish	  oil,	  colestipol,	  and	  Zetia)	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provided	  a	  rationale	  against	  a	  statin.	  	  Nearly	  one-­‐third	  of	  the	  sampled	  diabetic	  population	  were	  not	  on	  statin	  therapy.	  	  Furthermore,	  only	  one	  patient	  had	  diabetes	  listed	  as	  a	  rationale	  in	  the	  medication	  template;	  and	  one	  patient	  that	  was	  on	  a	  statin	  had	  no	  rationale	  listed	  for	  its	  use.	  	   Evidence-­‐based	  guidelines	  are	  useful	  only	  if	  the	  knowledge	  contained	  in	  them	  is	  translated	  into	  clinical	  practice.	  	  “Primary	  prevention	  measures	  are	  underused	  in	  general	  practice”	  (AHA/ASA,	  2011).	  	  Barriers	  that	  might	  attribute	  to	  this	  could	  be	  the	  patient’s:	  perceived	  susceptibility,	  cost-­‐benefit,	  lack	  of	  insurance,	  lack	  of	  knowledge	  of	  stroke	  risk,	  and	  noncompliance	  (AHA/ASA,	  2011;	  Holloway,	  Benesch,	  &	  Rush,	  2000).	  	  The	  public’s	  perception	  of	  prevention	  services	  are	  also	  found	  to	  be	  utilized	  less	  due	  to	  not	  having	  an	  immediate	  observable	  outcome	  (Holloway	  et	  al.,	  2000).	  	  In	  addition	  to	  these	  patient	  barriers,	  providers	  themselves	  may	  lack	  current	  knowledge	  of	  the	  evidence-­‐based	  practice	  guidelines	  for	  the	  prevention	  of	  stroke	  and	  the	  management	  stroke-­‐risk	  factors	  (Holloway,	  Benesch,	  &	  Rush,	  2000).	  	  
Limitations	  	   The	  limitations	  in	  this	  study	  were	  few,	  but	  notable.	  	  Due	  to	  time-­‐restraints	  each	  provider	  note	  for	  every	  patient/every	  visit	  for	  the	  inclusion	  dates	  could	  not	  be	  extracted	  for	  rationales.	  	  These	  rationales	  may	  include	  education	  of	  patient	  for	  stain	  therapy	  or	  why	  the	  provider	  thought	  statin	  therapy	  was	  or	  was	  not	  needed.	  	  	   Since	  the	  data	  were	  collected	  only	  from	  the	  patient’s	  active	  medical	  problem	  and	  active	  medication	  lists,	  rationales	  were	  unable	  to	  be	  obtained;	  unless	  the	  provider	  included	  the	  reason	  for	  the	  statin	  in	  the	  medication	  prescription	  template.	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Therefore,	  a	  rationale	  could	  not	  be	  found	  against	  treatment	  for	  patients	  who	  were	  not	  on	  statin	  therapy.	  	  However	  two	  patients	  on	  Zetia	  had	  “statin-­‐intolerance”	  listed	  for	  reason	  within	  the	  prescribing	  medication	  template.	  	   In	  collecting	  the	  data	  several	  errors	  were	  found	  entered	  on	  patient’s	  height.	  Differing	  heights	  were	  entered	  on	  many	  patients	  at	  each	  visit	  (ranging	  from	  5	  to	  7	  ft	  on	  the	  same	  patient),	  making	  it	  difficult	  to	  obtain	  an	  accurate	  BMI.	  	  In	  addition,	  some	  patients	  were	  on	  a	  hypertensive	  medication	  (e.g.,	  Lisinopril-­‐Hydrochlorothiazide)	  but	  had	  no	  listing	  diagnosis	  of	  hypertension.	  	  Therefore,	  incorrect	  data	  entry	  and	  lack	  of	  entry	  from	  ancillary	  staff	  as	  well	  as	  providers	  must	  be	  considered.	  	  In	  March	  2013,	  the	  Ambulatory	  Electronic	  Health	  Record	  (AEHR)	  was	  introduced	  to	  the	  clinic.	  	  This	  may	  have	  attributed	  the	  electronic	  records	  being	  incomplete	  from	  conversion	  from	  paper	  to	  electronic	  format.	  
	   Lastly,	  a	  provider	  focus	  group	  was	  scheduled	  to	  submit	  the	  findings	  of	  the	  retrospective	  chart	  review	  and	  to	  assess	  the	  facilitators	  and	  barriers	  in	  adhering	  to	  the	  primary	  stroke	  prevention	  guidelines,	  but	  was	  unfortunately	  cancelled	  due	  to	  circumstances	  beyond	  the	  primary	  investigator’s	  control.	  	  
Implications	  for	  Practice	  
	  
	   It	  has	  been	  shown	  that	  (a.)	  diabetics	  have	  a	  higher	  risk	  of	  stroke,	  (b.)	  diabetics	  have	  a	  higher	  risk	  of	  dyslipidemia,	  and	  (c.)	  women	  have	  a	  higher	  risk	  of	  metabolic	  syndrome	  and	  stroke	  (AHA/ASA,	  2011;	  AHA,	  ASA,	  2014;	  Air	  &	  Kissela,	  2007;	  CDC,	  2011;	  Colhoun	  et	  al.,	  2004;	  Cheung	  et	  al.,	  2004;	  De	  Vries	  et	  al.,	  2012;	  Heart	  Protection	  Study,	  2002;	  Hewitt	  et	  al.,	  2012;	  Karsito,	  2008;	  Kearney,	  et	  al.	  2008;	  Lakhan	  et	  al.,	  2010;	  Page	  et	  al.,	  2012).	  	  The	  obligation	  towards	  protecting	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women	  against	  disability	  and	  death	  from	  stroke	  is	  of	  great	  magnitude.	  	  To	  date	  there	  is	  only	  one	  guideline	  specific	  to	  primary	  stroke	  prevention	  and	  specific	  to	  women.	  	  Further	  research	  is	  needed	  to	  protect	  women	  with	  diabetes	  from	  stroke.	  	  	   Evidence	  has	  been	  delivered	  and	  recommendations	  made	  to	  provide	  all	  diabetics,	  (especially	  women	  who	  are	  at	  higher	  risk)	  primary	  prevention	  against	  stroke	  with	  statin	  therapy.	  	  All	  adult	  individuals	  should	  be	  knowledgeable	  of	  stroke	  and	  stroke	  risk	  factors,	  especially	  women	  who	  are	  at	  higher	  risk.	  	  In	  conjunction	  with	  providing	  important	  personal	  health	  maintenance,	  the	  primary	  healthcare	  provider	  should	  seek	  to	  identify	  specific	  risk	  factors,	  educate	  their	  patients	  in	  ways	  to	  reduce	  these	  risks,	  and	  advise	  therapeutic	  interventions	  as	  warranted	  based	  on	  the	  AHA/ASA	  guidelines.	  	  An	  aggressive	  approach	  to	  screening,	  establishing	  the	  presence	  of	  specific	  stroke	  risk	  factors,	  and	  intervening	  will	  reduce	  the	  prevalence	  of	  first	  stroke.	  	  In	  turn,	  reducing	  its	  calamitous	  consequences	  that	  plague	  our	  society	  and	  contribute	  to	  the	  rising	  costs	  of	  healthcare.	  	   	   	  	   The	  importance	  of	  modeling	  and	  introducing	  a	  clinical	  practice	  guideline	  aimed	  at	  reduction	  of	  first	  stroke	  in	  women	  cannot	  be	  over	  estimated.	  	  The	  importance	  lies	  in	  the	  potential	  to	  individually	  and	  publically	  integrate,	  in	  an	  efficient	  and	  effective	  manner,	  the	  evidenced	  based	  clinical	  guidelines	  established	  by	  the	  AHA/ASA,	  and	  to	  promote	  awareness	  of	  the	  ability	  to	  reduce	  primary	  stroke	  incidence	  while	  better	  managing	  control	  over	  modifiable	  stroke	  risk	  factors.	  	   Evidence-­‐based	  guidelines	  are	  ineffective	  if	  unable	  to	  be	  applied	  to	  practice.	  One	  of	  the	  main	  roles	  of	  the	  primary	  care	  provider	  (PCP)	  is	  health	  promotion	  and	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disease	  prevention.	  	  The	  PCP	  is	  responsible	  for	  being	  up	  to	  date	  on	  the	  latest	  evidence-­‐based	  treatment	  and	  prevention	  techniques.	  	  The	  PCP	  should	  make	  efforts	  to	  improve	  stroke	  prevention	  practices	  individually	  and	  identify	  and	  treat	  stroke	  risk	  factors	  in	  all	  patients,	  regardless	  of	  presenting	  illness	  (Holloway,	  Benesch,	  &	  Rush,	  2000).	  	  The	  translation	  of	  evidence-­‐based	  guidelines	  may	  prove	  difficult	  for	  many	  reasons.	  	  Holloway,	  Benesch,	  and	  Rush,	  (2000)	  state	  the,	  “	  the	  goal	  is	  to	  create	  a	  supportive	  practice	  environment	  to	  provide	  cues,	  resources,	  and	  support	  to	  promote	  desired	  behavior	  change”.	  	  Providers	  can	  increase	  stroke	  awareness	  and	  prevention	  strategies	  among	  their	  patients	  in	  several	  ways;	  educational	  materials	  around	  office,	  waiting	  rooms,	  and	  exam	  rooms;	  using	  computerized	  chart	  remainders;	  patient	  flow-­‐sheets;	  office	  policies	  emphasize	  stroke	  screening	  in	  all	  patients;	  post-­‐card	  reminders;	  and	  being	  familiar	  with	  community	  services	  (AHA/ASA,	  2011;	  Holloway	  et	  al.,	  2000).	  	  The	  strategy	  that	  had	  the	  best	  outcome	  in	  cardiovascular	  risk	  reduction	  measures	  was	  computer	  based	  clinical	  reminders,	  when	  compared	  to	  a	  control	  (AHA/ASA,	  2011).	  	  “Passive	  dissemination	  of	  information,	  as	  in	  publishing	  guidelines	  or	  traditional	  CME	  courses,	  are	  generally	  ineffective	  and	  at	  best	  results	  only	  in	  very	  small	  effects	  on	  physician	  practices”	  (Holloway	  et	  al.,	  2000).	  	  A	  variety	  of	  active	  prompts	  and	  office	  strategies	  are	  needed	  to	  ensure	  the	  best	  chance	  of	  provider	  adherence	  to	  guideline	  recommendations	  (Holloway	  et	  al.,	  2000).	  	  	  The	  data	  of	  this	  inquiry	  project	  will	  be	  disseminated	  to	  the	  providers	  of	  the	  reviewed	  clinic	  at	  a	  later	  date.	  	  Recommendations	  of	  computer-­‐based	  prevention	  reminders	  will	  be	  suggested,	  if	  not	  already	  utilized.	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   Clearly,	  more	  research	  is	  needed	  to	  identify	  feasible	  strategies	  to	  improve	  the	  dissemination	  and	  application	  of	  evidence-­‐based	  stroke	  prevention	  guidelines.	  The	  goal	  will	  be	  to	  create	  a	  universal	  tool	  to	  improve	  identification	  of	  stroke	  risk	  factors,	  interventions	  needed,	  and	  measured	  adherence.	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Appendix	  A	  Pt.	  #	   Hysterectomy	  Age	   HRT	  Race	   Age	  of	  Menopause	  Insurance	   Statin	  Smoker	   Rationale	  For	  Statin	  Alcohol	   Rationale	  Against	  Statin	  BMI	   Medication	  #1	  Systolic	  BP	   Medication	  #2	  Dystolic	  BP	   Medication	  #3	  Diabetes	  Type	  1	   Medication	  #4	  Diabetes	  Type	  2	   Medication	  #5	  Hypertension	   Medication	  #6	  A-­‐fib	   Medication	  #7	  Dyslipidemia	   Medication	  #8	  Previous	  CVA	   Medication	  #9	  Previous	  TIA	   Medication	  #10	  MI	   Medication	  #11	  PVD	   ICD-­‐9	  #1	  CAD	   ICD-­‐9	  #2	  CABG	   ICD-­‐9	  #3	  Stenosis	  of	  Any	  Atery	   ICD-­‐9	  #4	  Circulation	  Problems	   ICD-­‐9	  #5	  Migraine	  with	  Auras	   ICD-­‐9	  #6	  Menopause	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Figure	  1	  
	  	  Figure	  2	  
	  	  
• Out	  of	  the	  sample	  of	  100	  Diabetic	  Patients:	  
o 82%	  had	  a	  diagnosis	  of	  dyslipidemia	  
o Only	  69%	  were	  on	  a	  prescribed	  statin	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Figure	  3	  
	  Figure	  4	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  Figure	  5	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Conclusion	  	  	   The	  factors	  influencing,	  preventing	  and	  treating	  stroke	  is	  multi-­‐focal	  and	  require	  further	  study	  and	  implementation	  to	  reduce	  its	  prevalence	  and	  dismal	  consequences.	  	  	  	   	   	   	   	   	   	   	   	  	   As	  the	  first	  manuscript	  describes,	  stroke	  knowledge	  is	  markedly	  limited.	  	  Failures	  in	  patient	  knowledge	  of	  risk	  factors	  and	  recognition	  of	  stroke	  symptoms	  have	  impact	  on	  stroke	  occurrence	  and	  pre-­‐hospital	  delay	  in	  seeking	  treatment.	  	  Although	  evidence-­‐based	  guidelines	  for	  identification	  and	  treatment	  of	  stroke	  risk	  factors	  have	  been	  published,	  dissemination	  of	  this	  information	  into	  the	  public	  sphere	  has	  been	  lacking.	  	  Appropriate	  and	  successful	  educational	  medium(s)	  to	  impart	  this	  information	  remains	  problematic.	  	  The	  educational	  interventions	  that	  demonstrated	  the	  most	  effective	  approaches	  in	  accomplishing	  a	  reduction	  in	  stroke	  rate	  and	  improvement	  in	  acute	  interventions	  were;	  intense	  individual	  counseling	  (at	  an	  early	  age	  if	  possible);	  and	  a	  much	  broader	  scope	  of	  mass	  media.	  	  Generic	  public	  educational	  tools,	  e.g.,	  written	  materials,	  surveys	  and	  posters,	  were	  found	  to	  be	  much	  less	  effective	  and	  limited	  in	  scope.	  	  Any	  educational	  tool	  must	  be	  predicated	  on	  a	  thorough	  evidence-­‐based	  knowledge	  of	  stroke	  as	  well	  as	  an	  understanding	  of	  the	  socio-­‐economical	  and	  psychological	  environment,	  contingent	  attitudes,	  opinions,	  and	  behavioral	  patterns	  of	  the	  targeted	  audience.	  	  	   	   	   	  	   The	  second	  manuscript	  detailed	  a	  critical	  analysis	  of	  the	  AHA/ASA	  (2014)	  Clinical	  Practice	  Guideline	  for	  The	  Prevention	  of	  Stroke	  in	  Women,	  using	  a	  modified	  version	  of	  the	  Appraisal	  of	  Guidelines	  for	  Research	  and	  Evaluation	  (AGREE)	  Instrument	  (2001).	  	  Women	  have	  been	  found	  to	  have	  a	  higher	  overall	  prevalence	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and	  mortality	  associated	  with	  stroke	  than	  their	  male	  counterparts.	  	  All	  adult	  individuals	  should	  be	  knowledgeable	  of	  stroke	  and	  stroke	  risk	  factors,	  especially	  women.	  	  In	  conjunction	  with	  providing	  important	  personal	  health	  maintenance,	  the	  advanced	  practice	  nurse	  should	  seek	  to	  identify	  specific	  risk	  factors,	  educate	  their	  patients	  in	  ways	  to	  reduce	  these	  risks,	  and	  advise	  therapeutic	  interventions	  as	  warranted	  based	  on	  the	  AHA/ASA	  guidelines.	  	  An	  aggressive	  approach	  to	  screening,	  establishing	  the	  presence	  of	  specific	  stroke	  risk	  factors,	  and	  intervening	  will	  reduce	  the	  prevalence	  of	  first	  stroke.	  	  	   	   	   	   	   	   	  	   The	  final	  manuscript	  detailed	  the	  results	  of	  a	  descriptive	  study,	  examining	  provider	  adherence	  to	  prescribing	  a	  statin	  to	  all	  diabetic	  patients	  for	  primary	  prevention	  of	  stroke,	  regardless	  of	  dyslipidemia.	  	  This	  study	  took	  place	  in	  a	  women’s	  primary	  care	  clinic.	  	  	  Evidence	  has	  been	  delivered	  and	  recommendations	  made	  to	  provide	  all	  diabetics,	  (especially	  women	  who	  are	  at	  higher	  risk)	  primary	  prevention	  against	  stroke	  with	  statin	  therapy.	  	  	   	   	   	   	   	   	  	  	   In	  summary,	  it	  has	  been	  shown	  that	  stroke	  knowledge	  is	  lacking	  despite	  high	  stroke	  prevalence.	  	  Women	  and	  diabetics	  are	  at	  an	  increased	  risk	  for	  stroke	  and	  primary	  statin	  therapy	  can	  be	  used	  among	  the	  diabetic	  population	  for	  reduction	  in	  first	  stroke.	  	  The	  importance	  of	  these	  findings	  lies	  in	  the	  potential	  to	  individually	  and	  publically	  integrate,	  in	  an	  efficient	  and	  effective	  manner,	  the	  evidenced	  based	  clinical	  guidelines	  established	  by	  the	  AHA/ASA,	  and	  to	  promote	  awareness	  of	  the	  ability	  to	  reduce	  primary	  stroke	  incidence	  while	  better	  managing	  control	  over	  modifiable	  stroke	  risk	  factors.	  	  The	  obligation	  towards	  protecting	  women	  against	  disability	  and	  death	  from	  stroke	  is	  of	  great	  magnitude.	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